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A b s t r a c t
The esxl locus is important because it is associated with virulence in pathogenic 
mycobacterium including Mycobacterium tuberculosis, Mycobacterium leprae, 
Mycobacterium marinum, Mycobacterium bovis, Corynebacterium diphtheria etc. The 
presence of an orthologous locus in Streptomyces coelicolor, a Gram-positive non- 
pathogenic filamentous bacterium, is an exciting finding o f comparative genomics 
(Pallen 2002). Clues to the function of the genes were elucidated from analyzing the 
genes in S. coelicolor by in vitro transposon mutagenesis. Reverse transcriptase 
experiments indicated that esxB (SC05724) and esxA (SC05725) are co-transcribed and 
encoded by a single mRNA species. That the products of these two genes can interact 
was confirmed by two-hybrid analysis using translational fusions of the two proteins. 
Phenotypic studies of the knockout mutants revealed a delay in spore chain maturation. In 
addition, the presence of bldB divergently transcribed away from the esxAB operon and 
evidence o f bldB dependent regulation of the operon suggest that the genes may have a 
role in morphogenesis. Finally, data is presented indicating that EsxAB proteins are 
secreted via a dedicated system encoded by other genes of the esxl locus.
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CHAPTER I 
INTRODUCTION
1.1 Classification.
1.1.1 Actinomy cetes.
Actinomycetes are Gram-positive bacteria with a high guanine (G) plus cytosine(C) 
genome composition of 55 per cent or over. Organisms belonging to this genus are 
capable of unicellular or multi-cellular life styles. Actinomycetales are vigorous 
secondary metabolite producers responsible for the production of approximately 9000 
different compounds. Remarkably the majority of the compounds are generated by the 
genus Streptomyces (Watve et a l 2001).
1.1.2 Streptomyces.
Initially regarded as intermediate between bacteria and fungi, the mystery of the genus 
attracted the pioneer in the field Dr David Hopwood. It was at Strangeways 
Laboratory that with the help of electron microscopy, Dr Hopwood established that 
Streptomycetes lack a nuclear membrane and thus belong to the bacteria 
Superkingdom (Hopwood 1999). Streptomycetes have a large linear chromosome 
with a high guanine (G) plus cytosine(C) DNA content o f circa 70 per cent. 
Streptomycetes are multicellular organisms with a developmentally complex life cycle 
that consist o f three differentiation stages: they emerge as filamentous vegetative 
growth, followed by the formation of aerial hyphae and the differentiation of these 
hyphae into dispersive unigenomic spores as reviewed by (Paradkar et a l 2003). 
These organisms have been studied for over 50 years because they produce valuable 
bioactive compounds. Streptomycetes are described as environmental organisms, with 
a core of essential genes and two arms containing conditionally adaptive genes that 
are not essential but that allow the bacteria to survive by metabolizing a great variety 
of substrates (Bentley et al. 2002). Streptomycetes were taxonomically classified by
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(Williams et a l 1983) using cytochemistry and morphological analysis. They ordered 
as many as 325 species and grouped them in two clusters: 19 major and 40 minor 
clusters.
1.1.3 Model organism Streptomyces coelicolor A3 (2)
Embraced by Dr David Hopwood in 1954 because of its blue colour, this species was 
obtained from a collection of spores owned by Dr D. M. Webley that originally came 
from The Royal College of Technology in Glasgow (now Strathclyde University). 
Streptomyces coelicolor A3(2) produces four antibiotics: pigmented
undecylprodigiosin (Red, mycelium pigment) and actinorhodin (pH dependent, 
secreted blue pigment), methylenomycin and calcium dependent antibiotic (Hopwood 
1999). The genome sequence o f Streptomyces coelicolor strain M l45, a prototrophic 
derivative of Streptomyces coelicolor A3 (2) lacking its two plasmids SCP1 and SCP2 
was recently published (Bentley et al. 2002).
1.2 Ecology of Streptomycetes.
1.2.1 Natural habitat
Streptomycetes inhabit the oligotrophic soil environment. Streptomyces are 
saprophytes that perform a fundamental role in the degradation o f biopolymers chitin 
and ligno-cellulose (Hodgson 2000). The soil is a constantly ever-changing 
environment where a large variety of organisms co-exist. Their genome composition 
reflects the unsteady nature of their surroundings acquiring a vast array o f metabolic 
pathways to metabolize different types of substrates. They are readily isolated from 
soil, where they mostly exist as spores that can survive in soil for long periods. Their 
ability to form a mycelium network provides them with an advantage to grow on drier
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soils. Germination is density dependent within spores o f the same species. Studies 
confirmed that Streptomycetes colonise the plant rhizosphere and the marine sediment 
(Jensen et a l 1991). Although saprophytes, some species are also pathogenic having a 
choice of hosts. S. scabies and S. acidiscabies colonise the surface o f potato tubers 
causing great economical loss. S. somaliensis is the causative agent of 
actinomycetoma in animals and humans (Proctor 1966; Bukhalid and Loria 1997; 
Bramwell et a l 1998; Toth et a l 2001).
1.3 Morphological differentiation of Streptomyces coelicolor.
Growth in Streptomycetes is divided in three stages each having a characteristic 
differentiated cell type. A spore sensing appropriate conditions germinates. Usually 
spores produce one or two germ tube/s that start to grow into vegetative mycelia. 
Vegetative growth expands into the agar or soil by tip extension o f the cell wall 
forming a radial pattern of expansion (Flardh et a l 1999). The substrate hyphae 
contain multiple copies of the chromosome. When a septum is positioned on the 
substrate hyphae this hyphae stops growing until the next lateral branch emerges. 
Lateral branching allows the filaments to grow rapidly at a quasiexponential rate of 
development. As growth progresses the innermost parts of the colony accumulate 
excessive amounts of storage compounds: glycogen, lipids and polyphosphate. Then 
their growth stalls. It seems their growth stops because o f the lack o f one type of 
nutrient although on the other hand, other nutrients exist in excess (Chater 1993). 
These parts o f the colony grow slowly. As the colony ages, the second type o f tissue 
begin to develop and secondary metabolites start to be produced. Aerial mycelia 
emerge from the substrate mycelia into the air breaking the surface tension. These 
filaments form a new mesh of growth into the air, growing and branching
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homogeneously throughout the whole colony posing the question of how nutrients are 
channeled from the bottom to the top of the colony (Miguelez et al. 1994). This 
growth is believed to be supported by a carefully regulated programmed cell death by 
which the substrate mycelia undergo a progressive disintegration. The cell wall 
remains intact to support the colony growth and perhaps the channeling o f nutrients to 
the upper parts o f the colony. Later, the aerial hyphae septate into chains of 
uninucleoid compartments, that eventually mature into dark-grey exospores. Aerial 
hyphae which do not differentiate into spores degenerate and die (Hardisson and 
Manzanal 1976; Hodgson 1992; Kelemen et al. 1998; Miguelez et al. 1999)
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Figure 1.1 Lifecycle of Streptomyces.
Multicellularity starts from a unigenomic spore chain upon sensing ideal conditions 
for germination, one or two germ tubes are formed. They grow in a quasi-exponential 
rate to give rise to a mycelial terrestrial network that burrows into the food matrix. 
Signal accumulation stalls the primary growth to start a new phase o f mycelial aerial 
growth into the air. About this time production o f secondary metabolites takes place. 
Aerial hyphae curl and mature into the air then the apical compartment septates into 
genomic spore chains. The hydrophobic properties o f the exospores allow their 
dispersal into the ecosystem allowing the opportunity to colonise new soils. The 
identity o f the key genes involved at different stages o f development is indicated. 
Modified from (Kieser 2000)
w h iE
sig F
w h iD
Figure 1.2 Electron m icrographs of the distinct tissues of Streptomyces coelicolor.
From left to right, substrate mycelia, aerial hyphae and mature hyphae differenciated 
into spore chains. (Claessen et al. 2006)
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1.4 Molecular genetics of development in Streptomyces coelicolor.
Three main regulatory cascades control Streptomyces developmental cycle. The bid 
cascade, the whi cascade and the sky cascade. Pathways are interconnected permitting 
the colony to progress, sensing the external conditions and to precisely react to them 
by controlling gene expression. The bid cascade, (bald, unable to form aerial hyphae) 
ensures correct aerial hyphae formation by sensing the environment and signalling the 
onset of aerial formation. The bid mutants are blocked prior to aerial hyphae 
formation and are frequently defective in secondary metabolism because aerial growth 
and antibiotic production seem to be globally regulated. The whi cascade regulates 
sporulation, the whi mutants characterised because of a distinctive light-grey colour. 
They erect aerial mycelia which are unable to mature into spores, thus lack the 
distinctive polyketide grey pigment found on a mature spore surface. The sky cascade 
controls the expression of the chaplin and rodling genes (Claessen et al. 2006).
The sky pathway functions to signal between the bid and whi cascades. The sky 
pathway operates after aerial hyphae are emerging from the aqueous environment, it 
signals that the aerial hyphae have left the soil and it dictates the expression of the 
rodlin and chaplin genes. The bid cascade manages the initiation of aerial 
development controlling the steps that lead to the initiation of aerial growth.
1.4.1 bid mutants
The range of genes resulting in a bald phenotype (regulatory proteins, primary 
metabolism genes and genes encoding stress response sigma factors) indicates that the 
bid cascade allows the bacteria to assimilate hyphal density and energy status with 
external conditions (nutrient availability and stress). Each bid gene is involved 
directly or indirectly in the synthesis, perception of, or response to different
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extracellular signalling molecules. Each signal induces the production of the next 
signal leading to the production of SapB. SapB is a small diffusible peptide that is 
believed to coat the aerial hyphae before they break the surface tension to emerge into 
the air. The ramS gene encodes the SapB peptide of 42 amino acids that is post- 
translationally modified to adopt a lantibiotic like structure. The Ram cluster is 
composed of ramS, ramR, ramAB and ramC. ramR is a response regulator that 
activates ramSCAB operon transcription by binding to the promoter region. ramR is 
not transcribed in bldA, bldB, bldH  and bldD, strongly suggesting that its transcription 
is triggered by the bid cascade. The C-terminus of RamC resembles that of lantibiotic 
modification enzymes. RamAB is an ABC transporter (Kodani et al. 2004; Kodani et 
a l 2005).
Since the first study of the bid genes by (Merrick 1976), many bid genes have been 
characterised, every discovery provides a new clue for this complex regulatory puzzle. 
The bldA gene encodes a leucyl-tRNA essential for the translation of the infrequent 
codon UUA (TTA-DNA). The genome sequence of S. coelicolor (Bentley et al. 2002) 
reveals that only 1.85 per cent of the genes in the 8.7 Mb genome contain a TTA 
codon. The TTA-containing genes include regulators of morphological differentiation 
and antibiotic production hence the pleiotropic phenotype of the bldA mutants. 
Among them are pathway specific activators for the biosynthesis of actinorhodin and 
undecylprodigiosin production ActIIORF4 and RedZ, respectively. As a consequence 
of that a bldA mutant is unable to produce either of the pigmented antibiotics (Lawlor 
et al. 1987). Femandez-Moreno et al. 1991 demonstrated that the regulatory gene is 
the sole and direct mean by which bldA exerts its effects on actinorhodin production. 
Thus, it appears that there is specific bldA governed regulators for secondary
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metabolism and development. A TTA codon is also present in bldH  is a homologue o f  
adpA of S. griseous, that controls aerial mycelium formation (Takano et al. 2003). A 
regulatory target of bldA has been identified. bldH  target encodes an extracellular 
protease inhibitor that could delay the digestion of the primary biomass until the 
colony is ready to progress to the aerial development phase (Chater 2006). bldB 
encodes a 99 amino acid peptide with a helix-tum-helix DNA binding motif. 
Structural and molecular analysis revealed that the product of the bldB gene has DNA 
binding activity. Eccleston et a l 2002 reported that BldB protein forms a higher order 
complex possibly a dimmer. The region comprising amino acids 20 to 78 are 
important for this interaction. Pope et al. 1998 indicated that tyrosine residue at 
position 21 was essential for BldB function; tyrosine residues may assist in protein -  
protein interactions or be phosphorylated. The bldB pleiotropic phenotype of the 
mutant indicates its role as a global regulator of morphogenesis, catabolite control and 
antibiotic production. Analysis of bldB expression using a reporter gene indicates that 
bldB is temporally regulated and controls its own activity. bldB is the most 
controversial of the bid genes not fitting into the hierarchical cascade proposed by 
Willey et al. 1993. Unlike most bid mutants its phenotype is not restored by growing 
in poor carbon sources, or by exogenous addition of SapB. bldC encodes a small 
DNA binding protein homologous to the DNA binding domains of the MerB family 
of transcriptional activators (Hunt et al. 2005). The gene is required for aerial mycelia 
formation, although the phenotype is partially rescued in rich media. bldC mutants 
have some defects in antibiotic production as they are unable to produce actinorhodin. 
The bldC gene is constitutively express and its transcription is independent of other 
bid genes. The MerB family members function as homodimers, they consist of an N- 
terminal highly conserved DNA binding domain and a specific C-terminal effector
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recognition motif. Transcription activation is triggered by effector binding. bldD 
encodes a small DNA binding protein that represses developmental genes during 
vegetative growth. BldD regulates three targets: the developmental sigma factor 
genes, whiG and bldN, and the putative transcription factor bdtA. Electrophoretic 
mobility shift and DNase I footprinting assays were used to characterized and align 
the sequences bound by BldD suggesting AGTgA (n)m TCACc as a consensus BldD 
operator. (Elliot et al. 2001; Elliot et a l  2003) The bldG product is a putative anti- 
anti sigma factor. bldG is homologous to anti- anti sigma factors SpoIIAB and RsbW 
from B. subtilis. It has been suggested that BldG blocks aerial mycelium formation by 
preventing the activation of a sigma factor required for development. Such a sigma 
factor has not yet been found (Bignell et a l 2000). The bldK  locus consists of five 
adjacent ORFs that specify homologues of the subunits of the oligopeptide-permease 
family o f the ATP-binding cassette. bldK  imports a signalling peptide of 655 Da 
encoded by the bldJ locus (Nodwell et a l  1996; Nodwell and Losick 1998). bldM, is a 
response regulator active in early and late stages of development (formally whiK) and 
was found to be an unconventional response regulator, with a putative helix -  turn -  
helix DNA binding motif (Molle and Buttner 2000). bldM  is grouped with bldD in the 
extracellular complementation cascade. bldM , like bldN, is transcribed at the time of 
aerial hyphae formation and during sporulation. In vitro transcription assays in 
conjunction with SI mapping analysis confirmed that a bldN directs the transcription of 
bldM. bldN  was initially defined as a whi mutant (whiN). Nevertheless the 
construction of a null mutant gave rise to a bid phenotype. Transcription of bldN  is 
dependent on both bldG and bldH  and native transcription is initiated at the time of 
aerial hyphae formation. The protein has an unusual N-terminal extension which is
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proteolytically processed at the time o f aerial hyphae formation, possibly modulating 
its activity (Bibb et al. 2000; Bibb and Buttner 2003).
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Figure 1.3 Model of the hierarchical extracellular signalling complementation 
cascade in S. coelicolor.
Aerial hyphae development occurs as the culmination o f bid genes signalling (Chater 
and Chandra 2006). Signal 1 consists of the uptake of the product o f the bldJ locus by 
bldK, an oligopeptide permease this process activates the synthesis o f bldL/bldK 
dependant signal 2. BldA influences development via bldH  expression. Signal 3 
triggers regulatory gene anti-anti sigma factor bldG, upon which signal 4 is 
dependant. bldC is a gene that influences bldD a DNA binding protein and bldM. 
Culminating in the production of morphogens that drives aerial mycelium formation. 
There are still factors that have been discovered that don’t fit into the cascade as 
initiation of aerial mycelium formation is a complex signal transduction network.
Chaplins, rodSns
„  ...Signal
Start
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Table 1.1 Classical bid mutants.
Locus or loci Gene product(s)
bldA Leucyl tRNA required for the
translation of unusual codon UUA
bldB
bldC
bldD
bldG
bldJ
bldH
bldK
bldM
bldN
DNA binding protein with a helix- 
tum-helix motif
Putative transcriptional activator of 
the MerR family
DNA binding protein that binds to 
whiG, bldN  and sigH  
Putative anti- anti sigma factor 
Putative first signal of bid cascade
Homologue of A dp A contains an TTA
codon target of BldA
ABC family oligopeptide permease
Response regulator
Extracytoplasmic function sigma 
factor
References
(Merrick 1976; Lawlor 
et al. 1987; Chater 
2006)
(Pope et al. 1998; 
Eccleston et a l  2002) 
(Hunt et al. 2005)
(Elliot et al. 2001; 
Elliot et al. 2003) 
(Bignell et al. 2000) 
(Nodwell and Losick
1998)
(Takano et al. 2003; 
Chater 2006)
(Nodwell et al. 1996; 
Nodwell and Losick
1998)
(Molle and Buttner 
2000)
(Bibb et al. 2000; Bibb 
and Buttner 2003)
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Table 1.2 Additional genes involved in aerial hyphae formation in S. coelicolor.
Modified from (Claessen et al. 2006).
Locus or loci Gene product(s) References
acoA Aconitase citrate. Acidification of culture broth (Viollier etal. 2001)
partially responsible for the phenotype
amfC  Unknown; delayed and reduced aerial growth (Yonekawa et al.
1999)
brgA Unknown (Shima etal. 1996)
catB Developmentally regulated catalase. Mutants (Cho et al. 2000)
are hypersensitive to osmotic stress
(Claessen et al. 2003; 
Elliot et al. 2003;
chpA-H  Group of genes encoding the chaplin family of
proteins. Structurally impaired in development 
when deleted. Claessen et al. 2004)
citA Citrate synthase. Fails to form aerial hyphae due (Viollier etal. 2001)
to reversible acidification of culture medium
clpPl Subunit of ATP-dependant protease (de Crecy-Lagard et
al. 1999)
cya Adenylate cyclase, peptide permease. Fails to (Viollier et al. 2001)
form aerial hyphae due to reversible 
acidification of culture medium
osaAB Response regulator (Bishop et al. 2004)
Gene cluster involved in synthesis, modification (Ma and Kendall 1994;
and putative transport of the SapB precursor I Nguyen et al. 2002; 
RamR Kodani et al. 2004)
(p)ppGpp synthetase, delay aerial growth Sun 2001
rsuA Anti-sigma factor (Gehring etal. 2001)
sigB RNA polymerase sigma factor (oB) controlling (Cho etal. 2001)
the expression of catB
ramCSABR
relA
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1.4.2. The whi mutants.
By searching for colonies that lack the polyketide spore pigment many whi loci have 
been identify. Fourteen loci have been discovered and characterised so far. 
Transcription from the whiEPl and whiEP2 promoters is developmentally regulated 
(Kelemen et a l 1996). Experimental evidence suggested that whiEP2 is indirectly 
controlled by aF. Abolition of whiEP2 results in a green spore phenotype, therefore 
sigF  specifies the component of the spore pigment without directing its production. 
Early whi genes dictate the expression of the whiEPl and whiEP2 promoters. The 
factors that trigger sporulation seem to be a complex cascade in which the lack of 
linearity o f the path way is evident because of the many alleles that result from 
abolishment of individual whi genes. Two independent pathways lead to sporulation 
in Streptomyces coelicolor, one of the pathways is regulated by whiG and another is 
w/zz'G-independent. WhiG is a sigma factor. Mutants of the gene cause the aerial 
hyphae to be infrequently septated and its over-expression results in premature 
sporulation. Sigma whiG specifically initiates the developmental program that leads to 
the production of spores. The importance of bldD acting as a repressor o f c whlG 
provides the first link between the bid and the whi genes. When active, awh,G RNA 
polymerase holoenzyme transcribes early sporulation regulatory genes whiH  and whil. 
The products of these auto regulatory genes are proteins with a DNA binding domain 
and a signal sensing domain.
1.5 Physiology
1.5.1 Primary metabolism.
Research into primary metabolism in Streptomyces has been eclipsed by more 
extensive analysis of the secondary metabolites. Primary metabolism research
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received more impetus with the completion of the genome sequence and the discovery 
of thousands of novel genes (Bentley et al. 2002). Findings correlate with the 
ecological habitat o f the bacteria that feeds in the soil mainly on plant material. Plant- 
derived material is usually rich in carbon but deficient in phosphate and nitrogen and 
as a result considerable effort is invested by Streptomyces in multiple specific 
carbohydrate catabolic pathways (Hodgson 2000). In most Streptomyces the 
glycolysis pathway for glucose catabolism operates. The phosphoenolpyruvate: sugar 
phosphotransferase system (PTS) has also been reported in Streptomyces lividans, S. 
coelicolor and S. griseofuscus and is induced by fructose (Titgemeyer et al. 1995). 
Carbon catabolite repression (CCR) or the ability to metabolise a carbon source to 
prevent utilization o f less efficient carbon sources have been documented in 
Streptomyces. Streptomyces CCR is very different from other bacterial systems, in 
that it lacks the cAMP catabolite repressor protein and has the ability to inhibit 
antibiotic production. Nitrogen uptake occurs via glutamate synthetase (GS) and 
glutamate (Fisher and Wray 1989). Streptomyces have two GSs: GSI that resembles 
that of prokaryotes and GSII similar to those found on eukaryotes. Amino acid 
catabolism pathways in Streptomyces are conserved with the exception of arginine. 
More than half of the pathways studied are constitutive reflecting the low abundance 
of amino acid in their environment. Amino acid production pathways are analogous to 
those of other bacteria. The only difference is the lack of regulation, with 
Streptomyces pathways expressed at basal levels.
Streptomyces antibioticus accumulates glycogen and trehalose in a characteristic way 
during growth on solid medium. Glycogen storage in the substrate mycelium takes 
place during development of the aerial mycelium. The concentration of nitrogen 
source in the culture medium influences the time at which accumulation starts as well
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as the maximum levels of polysaccharide stored. Degradation o f these glycogen 
reserves was observed near the beginning of sporulation. The onset o f sporogenesis is 
always accompanied by a new accumulation of glycogen in sporulating hyphae 
(Brana etal. 1986).
1.5.2 Secondary metabolism.
Streptomyces have been a steady source of novel compounds for medical and 
pharmaceutical industries during the last fifty years since the discovery of 
streptomycin. The extensive repertoire of compounds that the genus produces 
includes: anti-parasitic, anti-viral and anti-cancer metabolites, immuno-suppresants, 
herbicides, insecticides and enzyme inhibitors. Many secondary metabolites produced 
by Streptomyces have a known biological function. Biotechnology advances have 
used Streptomyces as a host for the production of recombinant microbial products. 
Streptomyces were described by (Watve et a l 2001) as the largest antibiotic- 
producing genus in the microbial world discovered so far. Watve predicted that the 
number of antimicrobial compounds produce by this family is in the order o f 100,000 
compounds.
Normally, secondary metabolites begin to be produced at the end of the stationary 
phase of Streptomyces growth. Substrate mycelia expansion reaches an end and aerial 
mycelia begin to grow. Some hypotheses suggest that the role o f secondary 
metabolites is to protect the nutrients of the disintegrating substrate mycelia. Other 
propositions indicate that the secondary metabolites are an accumulation of stalling 
compounds as a result o f the growth of the colony.
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Several investigations were conducted to document antibiosis in soil where antibiotics 
were detected in non- sterile amended, sterile amended and unamended soils. 
(Williams et al. 1983; Wellington et a l 1990)
1.6 Streptomyces genetics
The completion of the genome sequence of S. coelicolor A3 (2), has provided 
Streptomyces research with a powerful tool. The total size of the chromosome is 
8,667,507 bp being the largest genome of the bacterial super kingdom. Exhaustive 
investigation of the genome sequence using in silico techniques is taking place that in 
turn will provide us with valuable information. Transcriptome and proteome analysis 
will aid our understanding o f microbial life in soil and facilitate the finding of new 
metabolites for further exploitation of the organism.
1.6.1 Genome structure
Streptomyces have a linear chromosome (Lin et al. 1993; Lezhava et al. 1995). 
During the long years that preceded the genome sequence project, many scientists 
studied its genetics still under the impression that Streptomyces had a circular 
genome. The first linkage map was introduced by Hopwood in 1958 (Hopwood
1999); a circular chromosome with six loci and two linkage groups. The origin of 
replication, oriC , and the dnaA gene are located 61Kb left o f the centre. Around the 
origin there is a decrease in the GC percentage facilitating the unwinding of the 
chromosome and hence DNA replication. Coding density is homogeneous along the 
chromosome with a slight decrease in the distal regions. The chromosome appears to 
be composed of a central core of essential genes and two chromosome arms. The 
central core region o f the chromosome extends from 1.5Mb to 6.4Mb and encodes
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genes essential for life e.g. cell division, DNA replication, transcription and 
translation machinery as well as the genes responsible for amino acid biosynthesis. 
The arms, uneven in length (1.5 and 2.3Mb), contain contingency genes, such as 
hydrolytic exoenzymes and ‘gas vesicle’ proteins (Bentley et al., 2002). Terminal 
inverted repeats (TIR) have been found on every Streptomyces species chromosome 
analysed. These TIRs can range from 24Kb in S. griseus to 550Kb in S. rimosus 
(Volff and Altenbuchner 1998). TIRs make up 21.6Kb in S. coelicolor. Initial 
comparisons with the complete genome sequence of S. avermitilis (Ikeda et al. 2003) 
revealed the conservation of an internal 6.5Mb region. A similar synteny was 
discovered by comparing S. coelicolor to two pathogenic Actinomycetes, 
Mycobacterium tuberculosis and Corynebacterium diphtheriae. The core region o f the 
S. coelicolor chromosome, containing genes for primary metabolic functions, has a 
genetic arrangement that is conserved in comparison to the whole genome of both the 
pathogens; inferring that they share a common ancestor.
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Figure 1.4 Combined physical and genetic map of the S. coelicolor M145 
chromosome
Outside of the circle are markers determined physically using the ordered cosmid 
library. Inside the circle are markers, which have mapped genetically and assigned by 
interpolation. AseI and Dral fragments are in Kb. ♦ indicates oriC  (Redenbach M
1.7 Mycobacterium tuberculosis and the ESAT- 6 family.
Tuberculosis is a threat to human life. The disease has been affecting mankind for 
over a century. However, exhaustive study of the bacteria has provided a vaccine for 
the disease and some treatments, but the modus operandim o f the causative agent M. 
tuberculosis is still elusive. Tuberculosis was declared a global epidemic on 1993 by 
the World Health Organization (WHO). One third of the world population is infected 
with 8 million people suffering the active form o f the disease and 2-3 million people 
dying every year. The scenario has been aggravated by the emergence of multidrug 
resistant strains and co-infection with HIV. In addition attenuated Bacille-Calmette- 
Guerin (BCG) derived from M. bovis that is the only available vaccine does not confer 
consistent protection against the disease. There are three main issues with BCG 
vaccination. Firstly it compromises diagnosis of the disease because it produces a 
delay type hypersensitivity response to protein purified derivative (PPD) that can not 
be distinguish from exposure to M. tuberculosis. The second disadvantage is that it is 
a live vaccine contraindicated to HIV patients and immuno-compromised individuals, 
and lastly BCG lacks the DNA segments present in pathogenic M. tuberculosis 
loosing some o f its immunogenicity. Diagnosis is also problematic with the protein 
purified derivative (PPD) lacking specificity due to the sharing of some cross-reactive 
antigens with BCG and some environmental mycobacteria. The tuberculin test when 
negative does not rule out active TB, and a positive result can not distinguish 
between, a) active disease, b) BCG vaccination or c) exposure of healthy individuals 
to environmental mycobacteria. For all the reasons outlined above, an exhaustive 
search for new diagnostic tools, vaccines and an ultimate clue to the way the 
bacterium operates started.
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Comparisons between virulent and avirulent mycobacteria identified region of 
difference 1, (RD1) as the main virulence determinant. RD1 is absent in all types of 
the attenuated M. bovis BCG vaccine strain and non-pathogenic mycobacteria. The 
esxl locus is located in the RD1 region. This encodes the ESAT-6 protein that was 
initially identified in the culture filtrate of M. tuberculosis hence the name Early 
Secreted Antigenic Target o f molecular size 6 kDa. Another protein encoded by the 
esxl locus and identified in early experiments was Culture Filtrate Protein of 10 kDa 
(CFP-10). These two proteins reacted strongly with the T-cell component of 
tuberculosis patient’s serum and therefore began to be studied in great detail (Berthet 
et al. 1998; Brodin et al.). The esat-6 and Ihp genes (as they were initially named 
before nomenclature changed to esxA and esxB, respectively) code for proteins that 
are secreted but lack any detectable secretion signals. ESAT-6 protein belongs to a 
family of 100-residue proteins abundant in M  tuberculosis characterised by the 
presence of a central WXG motif. The rest of the locus is composed of genes that 
code for cell-wall-associated serine proteases, putative ABC transporters, ATP- 
binding proteins and other membrane-associated proteins. Therefore the most logical 
explanation was that the genes coded for a novel secretion system of Gram positive 
bacteria. In M. tuberculosis the genes encoding these proteins lie in five large 
conserved clusters. The esxl locus is present in most mycobacteria strains and in S. 
coelicolor and Corynebacterium diphtheria.(Gey van Pittius et al. 2001; Pallen 2002). 
In S. coelicolor, there is one esxAB operon with the peculiarity that it is divergently 
transcribed from the important regulatory gene bldB. The locus in S. coelicolor 
resembles that of M. tuberculosis containing the genes that code for cell-wall- 
associated serine proteases, putative ABC transporters, ATP-binding proteins and 
other membrane-associated proteins indicating that the secretion apparatus could be
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functional in non- pathogenic bacteria like S. coelicolor (Figure 1.5). Further analysis 
of the M. tuberculosis esxl locus revealed its importance for virulence and 
pathogenicity of Mycobacteria and also provided further information about which 
genes were essential for ESAT-6 and CFP-10 secretion.
In vivo Mycobacteria reside in the macrophages that are myeloid cells whose 
functions are to engulf and destroy foreign organisms. M. tuberculosis asserts a 
profound inhibitory influence on its host. The function of the ESAT-6 and CFP-10 
proteins is unknown. Deletion of esxA and esxB resulted in a diminution of virulence 
(Wards et al. 2000). All BCG strain deletions encompass the esxl locus (Mahairas et 
al. 1996). The incorporation of the RD1 region into BCG restores virulence and 
immunogenicity of the bacteria as demonstrated by several studies (Pym et al. 2002; 
Lewis et al. 2003; Pym et al. 2003). Stanley, Raghavan et al. 2003 were the first to 
name the novel secretion system in bacteria. The system was called the Snm secretion 
system (for Secretion iN Mycobacteria). Stanley’s study performed Western analysis 
to detect the proteins in the supernatant and cell pellets for the presence of ESAT-6 
and CFP-10 and they identified three essential components of the secretion apparatus 
and the required substrates. The three essential components are snm l (Rv3870) and 
snm2 (Rv3871) encoding amino-terminal transmembrane ATPases and snm4 
(Rv3877) codes for an integral membrane protein that contains 11 transmembrane 
domains. Study of mutants defective in any essential component o f the Snm system in 
vivo and in vitro, showed that each mutant displayed an attenuated phenotype similar 
to a mutant lacking the entire RD1 region (Guinn et al. 2004). Mutants were able to 
enter macrophages but then were not able to spread to uninfected macrophages 
resulting in reduced tissue invasiveness in lung tissue. In every case abolishment of
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secretion o f ESAT-6 and CFP-10 proteins was associated with a reduction in 
virulence and immunogenicity. A model of the Snm secretion system is illustrated in 
figure 1.6. All these evidence suggested that the clusters of Streptomyces coelicolor 
and Mycobacterium tuberculosis were analogous. Therefore if  I could prove that the 
S. coelicolor cluster was functional it could constitute a good model to discover the 
function of the genes in M. tuberculosis.
The benefits of studying the esxl genes in S. coelicolor were that the organism was 
more tractable in terms of its genetics, containing a unique copy of the esxl cluster 
and also its culturability.
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Figure 1.5 Schematic representations of the S. coelicolor and M. tuberculosis esxl 
locus.
The esxl locus in S. coelicolor genome contains seven genes homologous to the M. 
tuberculosis cluster. SC05721  is an amino-terminal transmembrane protein that 
contained an ATP/GTP binding site; SC05722 is a subtilisin like cell wall associated 
serine protease: SC05734  is a DNA segregation ATPase, ftsK-like chromosome 
partitioning protein (3x ATP/GTP binding sites) amino-terminal transmembrane 
protein.
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Figure 1.6 Diagram depicting a model of the M. smegmatis novel secretion Snm 
pathway.
The pathway resembles that o f M. tuberculosis. CM, cytoplasmic membrane; PG, 
3eptidoglycan layer; mAG, mycolyl arabinogalactan layer. (Converse and Cox 2005)
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Information about the complex formed by CFP-10 and ESAT-6 was elucidated by 
(Renshaw et al. 2002; Renshaw et al. 2005). They postulated that the secretion of the 
proteins was an active process involving a membrane protein complex formed by the 
products of the flanking genes. They showed that CFP-10 and ESAT-6 form a tight 
1:1 complex and that the C- terminus of CFP-10 is required for binding of the 
complex to the surface o f macrophage and monocyte cells.
The core of the CFP-10:ESAT-6 complex consists of two similar helix-tum-helix 
hairpin structures formed from the individual proteins. The CFP-10:ESAT-6 complex 
has an extensive hydrophobic contact surface and the two proteins lie anti-parallel to 
each other to form a four-helix bundle (Figure 1.6). N- and particularly C-termini of 
both proteins (residues 2-5 and 86-100 in CFP-10 and 1-3 and 86-95 in ESAT-6) 
form long flexible arms at both ends of the four-helix bundle core. The two long 
helices in the hairpin structures are formed from residues Ala8-Gln40 and Ala47- 
Ala79 in CFP-10, and from Phe8-Trp43 and Glu49- Ala79 in ESAT-6. The helices in 
CFP-10 are completely a-helical, whereas in ESAT-6 both long helices terminate with 
a single turn of helix and ESAT-6 also contains a short helix close to the N-terminus 
(Gln4-Trp6) (Renshaw et al. 2005).
Analysis of the electrostatic surface of the complex suggest that the surface of the 
complex has a very uniform distribution of positive and negative charge, with no hint 
of a significant hydrophobic patch ruling out the possibility o f the complex forming a 
membrane spanning pore. In addition, the complex does not seem to be involved in 
interactions with nucleic acids as the surface of the complex lacks any striking acidic 
or basic patches, clefts in the surface of the structure, the surface features of the CFP-
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10:ESAT-6 complex seem most consistent with a function based on specific binding 
to target protein/s, perhaps playing a key role in pathogen-host cell signalling.
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Figure 1.7 Schematic representations of the conformation adopted by the ESAT- 
6: CFP-10 heterodim er of M. tuberculosis.
Solution structure o f the CFP-10:ESAT-6 complex. (A) A best-fit superposition o f the 
protein backbone for the family o f 28 converged structures obtained, with CFP-10 
shown in red and ESAT-6 in blue. The long flexible C-terminal arms o f both proteins 
are clearly visible, as is the propensity to helical structure in this region of CFP-10.
(B ) A ribbon representation of the backbone topology o f the CFP-10:ESAT-6 
complex based on the converged structure closest to the mean, which illustrates the 
two helix-turn-helix  hairpin structures formed by the individual proteins. The 
orientation o f the complex is identical to that shown in panel A. with CFP-10 in red 
and ESAT-6 in blue. (Renshaw et al. 2005)
•fcSAT-6
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1.8 Protein secretion in bacteria.
Protein secretion is well documented in Gram negative bacteria. Most o f the current 
knowledge o f bacterial transport systems has derived from experiments carried out in 
Gram negative bacteria. There are three main transport routes to translocate substrates 
across the bacterial membrane:
Class 1 pathways translocate polypeptides and peptide subdomains across the 
cytoplasmic membrane. This pathway uses a different translocon for unfolded (Sec 
YEG/YidC) or for folded proteins (TAT ABC). Class 2 pathways are required for 
crossing the outer membrane from the periplasm, transporting proteins, in a folded 
state. Class 3 includes type I, type III, flagellar and the majority o f Type IV systems 
moving ‘unfolded’ proteins, directly from the cytoplasm to the outside (or into a host 
cell cytoplasm). Outer membrane translocons are most likely derived from a single 
ancestor whereas inner membrane translocons are usually specific to each pathway 
(Holland 2004).
The Type I pathway is usually dedicated for pore forming toxins consist o f an ATP- 
binding cassette (ABC) transporter. The family of repeat toxins (RTX toxins) are 
secreted this way. Gram negative bacteria use this system to transport virulence 
factors across the bacterial envelope. ABC transporters are used indistinctively by 
Gram negative, Gram positive bacteria and eukaryotes (from yeast to humans).
Type II substrates are transported in two stages, upon recognition of the signal 
peptide, sec machinery transports type II substrates across the plasma membrane. 
Then the folded substrates are the transported across the outer membrane.
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Type III secretion systems are activated when the bacteria touches the host cell. Some 
bacteria sense the ion concentration in the cytoplasm of the host cells as a mechanism 
to trigger type III secretion. Salmonella uses this mechanism to enter epithelial cells 
and inject factors to activate polymerisation of actin. All Type III machines have an 
outer membrane structure called secretin. Secretin promotes the assembly of a needle 
structure that directs the channelling of the protein into the host cell cytoplasm.
Type IV transport systems are complex machines, transporters o f proteins or nucleic 
acids that secrete substrates across the bacterial envelope or direct them into target 
cells. Two Gram negative pathogens, Agrobacterium tumefaciens and A. rhizogenes, 
infect specific plants to cause crown gall tumours, a weakening disease (Lai and Kado 
1998; Zupan et a l  2000). Plant cells within the tumour are transformed by 
agrobacterial DNA, which is inserted into nuclear chromosomes. Expression of the 
bacterial genes (tumour or T-DNA) results in the production o f opines (amino acids) 
that constitute a source of nutrient for the Agrobacteria (Zambryski et a l  1989). The 
bacterial virulence genes were found searching for genes that cause tumour 
production (Ward et a l  1988), several of which display homology to genes required 
for bacterial mating or conjugation. Conjugation requires physical contact with gram 
negative bacteria forming a pili that enable male (pili containing) bacteria to interact 
with female cells to proceed to the conjugation.
Pathways described above require a signal peptide that will target the substrate to the 
corresponding translocon. The lack of signal peptides for the secreted immunogens
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CFP-10 and ESAT-6 indicates that these proteins are exported by a novel secretion 
system of Gram positive bacteria.
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CHAPTER II 
MATERIALS AND METHODS
Chapter 2. Materials and methods
2.1 Bacterial strains
E. coli JM109 was principally used to perform genetic manipulations. Mobilisation of 
plasmids and cosmids into Streptomyces by intergeneric conjugation utilised the non 
methylating E. coli host ET12567/ pUZ8002.
Table 2.1 Bacterial Strains
Bacterial Strain Genotype Source |
S. coelicolor A3(2) M l45 Prototrophic SCPE SCP2" 
Pgl+
F’ traD36proA+B+ laclq 
A(lacZ)Ml 5/
A(lac-proAB) glnV44 e l 4- 
gyrA96 recAl 
relAlendAl thi hsdR17
(Kieser 2000) |
E. coli JM109 Promega Corp. 
Yanisch-Perron et al., 
(1985)
E. coli ET 12567 
(pUZ8002)
Daml3::Tn9 dcm6 hsdM
hsdR recF143 16
zjj201 ::Tn 10 galK2 galT22
aral4 lacYl
xyl5 leuB6 thil tonA31
rpsLl36 hisG4
tsx78 mtliglnV44,
containing the
nontransmissible
oriT mobilizing plasmid,
pUZ8002
(Flett e ta l  1997)
E. coli XL 10-Gold Tetr A{mcrA)183 A(mcrCB- 
hsdSMR-mrr)l 73 endA 1
Stratagene
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supE44 thi-1 recAl gyrA96 
relAl lac
StratageneE. coli XL 1-Blue MRF A(mcrA)183 A(mcrCB- 
hsdSMR-mrr) 173 end A 1 
supE44 thi-1 recAl gyrA96 
relAl lac [F'proAB 
lacIqZAM15 Tn5 (Kanr)]
BacterioMatch® II two- 
hybrid system reporter cells
A(mcrA)183 A(mcrCB- 
hsdSMR-mrr)17 3 endAl 
hisB supE44 thi-1 recAl 
gyrA96 relAl lac [F' laqlq 
lacZ ampR Kanr]
Stratagene
2.2 Plasmids
Plasmids and cosmids used in this study are listed in Table 2.2. The details regarding 
construction of plasmids originating from this study may be found in specific results 
chapters.
Table 2.2 Plasmids and cosmids
Plasmid/ Cosmid M arker genes Source
pBlueScript SK + bla Promega
pSAl bla I This study
pSA2 bla This study
pSF152 aadA derivative of 
pSET152
! P. Herron
pSH152 hyg derivative of pSET152 R. del Sol
pME6 kan bla j P. Dyson
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pALTER 1 bla tet Stratagene
pSA2mtl bla This study
pSA2m2 bla This study
PBT cat Stratagene
pTRG tet Stratagene
pBTCFP cat This study
pTRGEST tet This study
pRlux86 .aPL........................................... R. del Sol
pSAluxl apr This study
pSA152 aadA This study
PSAXhol bla R. del Sol
pSAHISl apr R. del Sol
PSAHIS2 hyg This study
pSAHIS3 hyg This study
pSA2633 hyg This study
pSA23 hyg This study
PQM5062 Tn5062 in pMOD<MCS> 
(Epicentre)
P. Herron
PQM5066 Tn5066 in pMOD<MCS> 
(Epicentre)
R. del Sol
pSX2633 hyg This study
pSAN2 apr tet This study
pSAN3 kan bla This study
SC3C3.2.B06 SC3C3 containing Tn5062 
in SC05721 bla kan 
aacS(IV) ohT(rk) eGFP
P. Herron
SC3C3.1.G11 SC3C3 containing Tn5062 
in SC05722 bla kan 
aac3(IV) oriT(RK) eGFP
P. Herron
SC3C3.1.H11 SC3C3 containing Tn5062 
in SC05724 bla kan 
aac3(IV) oriT(rk) eGFP
P. Herron
SC3C3.1.E07 SC3C3 containing Tn5062 
in SC05725 bla kan 
aac3(IV) ohT(rk) eGFP
P. Herron
SC3C3.2.C01 SC3C3 containing Tn5062 P. Herron
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in SC05725 bla kan 
aac3(IV) oriT(RR) eGFP
SC3C3.1.G05 SC3C3 containing Tn5062 
in SC05727 bla kan 
aac3(IV) oriT(RK) eGFP
P. Herron
SC3C3.2.F07 SC3C3 containing Tn5062 
in SC05728 bla kan 
aac3(IV) oriT(RK) eGFP
P. Herron
SC3C3.2.C02 SC3C3 containing Tn5062 
in SC05728 bla kan 
aac3(IV) oriT(RR) eGFP
P. Herron
SC3C3.2.F11 SC3C3 containing Tn5062 
in SC05729 bla kan 
aac3(IV) oriT{RR) eGFP
P. Herron 
P. HerronSC3C3.2.F10 SC3C3 containing Tn5062 
inSC05731 bla kan 
aac3(IV) oriT{w) eGFP
SC3C3.2.D08 SC3C3 containing Tn5062 
in SC05732 bla kan 
aac3(IV) oriT(RR) eGFP
P. Herron
SC3C3.2.C03 SC3C3 containing Tn5062 \ P. Herron 
in SC05733 bla kan 
aac3(IV) oriT{rk) eGFP |
SC3C3.2.B11 SC3C3 containing Tn5062 
in SC05731 bla kan 
aac3(IV) ohT(rk) eGFP
P. Herron
SC3C3.2.F08 SC3C3 containing Tn5062 
in SC05734 bla kan 
aac3(IV) oriT(xx) eGFP
P. Herron
|
SC3C3.2.C03 SC3C3 containing Tn5062 
in SC05735 bla kan 
aac3(IV) oriT(RR) eGFP
P. Herron
pSAN3. 3.FI 1 pSAN3 containing Tn5066 
in SC05723 bla kan Hyg 
oriT(RR) eGFP
S. Fielding
pSAN3. 3.F03 pSAN3 containing Tn5062 | S. Fielding 
in SC05726 bla kan Hyg 1 
oriT(]^k) eGFP
pSA23 hyg | This study
pRlux86 apr | This study
pSAluxl j apr This study
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2.3 Chemicals and medias
Constituents of the reagents used and growth media can be found in Tables 2.3 and 2.4, 
respectively. Fisher Scientific Ltd., BDH Chemicals Ltd., and SIGMA Chemical 
Company supplied the majority of the chemicals. Bacterial growth media were purchased 
from DIFCO, Oxoid Ltd., Gibco BRL and Lab M (idg).
Solutions and media were routinely autoclaved at 121°C, 15 psi for 30 min or filter 
sterilised with a 0.2pm filter. pH was measured at room temperature. The preparation of 
solutions requiring de-ionised water was provided by the MILLI-Q water purification 
system, dd^O  is ultra-pure deionised MILLI-Q water and dH20 is MILLI-Q RO (reverse 
osmosis).
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Table 2.3 Commonly used reagents
Reagents Ingredients Quantity per litre dH20 
(unless indicated otherwise*)
lO xTBE Tris
Boric Acid 
EDTA
108g
55g
9.3g
20 x SSC NaCl 175.5g
tri- Sodium citrate 88.2g
Bromophenol Blue Sucrose 40g
DNA loading dye* Bromophenol Blue 60 mg
1 xTBE 10 ml
dH20 90 ml
Buffer I Tris 12.lg
NaCl 8.8g
Buffer II Blocking reagent 0.25g
Buffer I
Microwave to dissolve
100 ml
Denaturing Buffer NaOH 20g
NaCl 87.75g
Neutralising Buffer Tris 121 g
NaCl 
pH 7.5
88g
Prehybridisation 20 x SSC 25 ml
solution* 10% N-Lauryl sarcosine (w/v) 1 ml
10% SDS (w/v) 200 pi
Blocking reagent 5g
Formamide 50 ml
dH20 24 ml
Colour solution* NBT/ BCIP Tablets (Roche) 1 tablet
ddH20 10 ml
Stacking gel (x2)* Acrylamide 650 pi
dH20 3 ml
1 M Tris pH6.8 1.25 ml
10% SDS 50 pi
10% TEMED 5 pi
10% APS 25 pi
Resolving gel (x2)* Acrylamide 6 ml
12% Polyacrylamide dH20 5 ml
1.5 M Tris pH8.8 3 ml
10% SDS 150 pi
10% TEMED 15 pi
10% APS 80 pi
Running buffer for Glycine 14.4 g
SDS-PAGE Tris 4 g
SDS 0.1 g
PAGE Sample 1M Tris-HCl pH6.8 500pl
loading buffer* 1M Dithiothreitol (DTT) 1 ml
10% SDS 2 ml
1% Bromophenol blue 1 ml
Glycerol 1 ml
ddH20 4.5 ml
Coomassie blue* Coomassie brilliant blue R250 0.25 g
Methanol 45 ml
dH20 45 ml
Glacial acetic acid
Filter through Whatman N° 1
filter
10 ml
Coomassie blue Methanol 450 ml
Destain solution* dH20 450 ml
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Glacial acetic acid 100 ml
42
Table 2.4 Growth medium
Media Ingredients Quantity per litre |
2x YT Tryptone 
Yeast Extract 
NaCl 
dH20
adjust pH to 7.0 with NaOH
16 g 
10g
5g
up to 1L
Luria Bertani (LB) Tryptone 10g
Broth Yeast Extract 5 g
NaCl 5 g
Glucose 1 g
dH20 up to 1L
adjust pH to 7.0 with NaOH
Luria Bertani (LB) Tryptone 10g
Agar Yeast Extract 5g
NaCl 5 g
Glucose 1 g
dH20 up to 1L
adjust pH to 7.0 with NaOH
then add agar 10g
Minimal Medium L-asparagine 0.5 g
k 2h p o 4 0.5 g
M gS04.7H20 0.2 g
FeS04.7H20 0.01 g
Agar 10 g
dH20 up to 1L
adjust to pH7.2 with NaOH
If supplementing the media,
add filter sterilised supplement
after autoclaving. i.e. glucose (1%
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w/v) or mannitol (0.5% w/v)
Nutrient Agar Oxoid Nutrient Broth 13 g
Agar 12 g
dH20 up to 1L
R2 Sucrose 103 g
K2S 0 4 0.25 g
MgCl2. 6H20 10.12 g
Glucose 10g
Casamino acids 0.1 g
Agar 22 g
dH20
After autoclaving add (to 200 ml):
up to 800 ml
Trace element solution 0.5 ml
5.73% TES Buffer pH7.2 25 ml
0.5% KH2P04 2.5 ml
5M CaCl2 1 ml
20% Proline 3.75 ml
1 N NaOH 1.25 ml
R2YE Sucrose 103 g
K2S04 0.25 g
MgCl2. 6H20 10.12 g
Glucose 10g
Casamino acids 0.1 g
Agar 22 g
dH20
After autoclaving add (to 200 ml):
up to 800 ml
Trace element solution 0.5 ml
5.73% TES Buffer pH7.2 25 ml
0.5% KH2P 04 2.5 ml
5 M CaCl2 1 ml
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20% Proline 
IN NaOH 
10% Yeast extract
3.75 ml 
1.25 ml 
12.5 ml
SFM (MS agar) Soya Flour 20 g
Mannitol 20 g
Agar 20 g
Tap water up to 1L
SOC Tryptone 20 g
Yeast Extract 5 g
1 MNaCl 10 ml
1 MKC1 2.5 ml
dH20
after autoclaving add:
up to 1L
1 M MgCl2.6H20 10 ml
1 M M gS04.7H20 10 ml
1 M Glucose 10ml
Tryptone Soy Broth Tryptone Soy Broth from Lab M 30 g
dH20 up to 1 L.
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2.4 Antibiotic selection
All antibiotics were made up as stock concentrations (Table 2.5) and unless stated made 
up in ddH20 and filter sterilised. Antibiotics were stored at -20°C with the exception of 
hygromycin that was stored at 4°C.
In some cases screening of colonies that result from cloning an insert that lacks a 
resistance marker is facilitated using blue/ white selection (if the plasmid contains a 
multiple cloning site within the lacZ gene). E. coli colonies containing plasmids with a 
disrupted lacZ gene may be identified because they are unable to produce p~ 
galactosidase, which converts the chromogenic substrate X-gal into an insoluble blue dye 
and therefore the colonies will be white. On the other hand if the plasmids are intact the 
(3-galactosidase enzyme will be active and the colony will be blue.
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Table 2.5 Concentration of antibiotics
Antibiotic Stock E. coli working Streptomyces working
concentration concentration concentration
( mg m l1) ( fig ml'1) ( Hg ml'1)
Ampicillin 50 50 -
Apramycin 25 100 25
Chloramphenicolr 10 10 -
Hygromycin 100 100 50
___ _ __
25 -
Kanamycin 25 25 25
Nalidixic acid2 20 20 -
Spectinomycin 200 50 400
Streptomycin 100 25 100
Tetracycline 10 10 -
X-gai4 20 25 -
To dissolve usefT00%  Ethanol,^25M N aO H 7r 80% Ethanol, 4DMSO
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2.5 Culture conditions
2.5.1 Growth and storage of E. coli
E. coli strains were grown on plates of LB agar or as liquid cultures, in LB broth. Strains 
were cultivated at 37°C and stored in the short term at 4°C.
2.5.2 Growth and storage of Streptomyces
The standard medium we used to propagate Streptomyces cultures is SFM (MS) agar. 
When doing so it was necessary to spread the inoculum over the entire surface of the 
plate in the presence of appropriate antibiotics. Streptomyces were grown for 
approximately 5 days at 30°C until they had fully developed. Streptomyces cell stocks 
were prepared from a plate of sporulating cells incubated on SFM; spores were collected 
by flooding the surface with 10 ml sterile ddfLO, and scraping off the surface with a 
sterile inoculating loop. The mixture was vortexed vigorously and then poured through a 
sterile 10 ml syringe with a cotton wool filter, to remove any pieces of agar and mycellia. 
Subsequently spores were pelleted at ca. 4000 rpm for 10 min and resuspended in 1 ml 
20% glycerol. Spore suspensions were stored at -20°C. Solid Streptomyces cultures were 
kept at 4°C in the short term.
For certain experiments like protein isolation and luciferase experiments Streptomyces 
mycelium was grown in liquid culture. For this purpose cultures needed to be grown in 
sterile flasks containing stainless steel springs to enhance dispersed growth and on an 
orbital shaker for the cultures to be ventilated with sufficient space in the flask for
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respiration. To accommodate this 250 ml flasks with were used and 50 ml cultures were 
incubated at 30°C, 225 rpm.
2.6 Transformation
2.6.1 Preparation of electrocompetent E. coli JM109
A 1/100 dilution of a fresh overnight E. coli JM109 culture was inoculated into 500 ml 
LB broth. At an OD600 0.5 -  0.7 the cells were chilled on ice for 20 min then harvested by 
centrifugation at 4000 rpm for 15 min at 4°C. The supernatant was decanted and the 
pelleted cells carefully resuspended in 500 ml ice cold 10% glycerol. The cells were then 
pelleted and resuspended in 250ml ice cold 10% glycerol. Finally cells were pelleted, 
resuspended in 20ml ice cold 10% glycerol pelleted again and resuspended into 2 ml ice 
cold 10% glycerol. The 2 ml suspension of electrocompetent JM109 cells was aliquoted 
out and stored at -70°C.
2.6.2 Transformation of electrocompetent E. coli JM109
A 40 pi aliquot of electro-competent cells (JM109) was thawed slowly on ice, 10 ng 
DNA was added and mixed gently by twirling the pipette tip. After a 2 min incubation on 
ice the mixture was transferred into a chilled electroporation cuvette then electroporated 
using a MicroPulser™ (BioRad). Immediately 1 ml SOC was added and the mixture was 
incubated in a Bijoux tube for 90 min at 37° C shaking at 225 rpm. The transformation 
mixture was plated onto LB agar with appropriate antibiotic selection.
2.6.3 Preparation of competent E. coli ET12567 for intergeneric conjugation
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E. coli ET12567 / pUZ8002 possess the machinery for interspecies conjugal transfer. The 
plasmid confers kanamycin resistance and the dam mutation is maintained by selection 
with chloramphenicol. A ten fold dilution of a culture grown to stationary phase was 
inoculated into LB broth with 0.5 M MgCh. Cultures were grown to exponential phase 
shaking at 250 rpm, 37°C. During the following steps the cells were kept on ice and all 
equipment was chilled before use. After two hours at 37° C the cells were incubated on 
ice for 10 min and then pelleted at 6000 rpm for 5 min. The pellet was gently 
resuspended in 10 ml ice cold 50 mM CaCh, incubated for 30 min, then pelleted again. 
This CaC^wash was repeated three times in total. After the final wash the pelleted cells 
were resuspended in 2 ml CaCL and stored at 4°C overnight. Transformation efficiency 
is enhanced during the first 24 h. Cells can be stored at - 70° C but transformation 
efficiency diminishes with storage time.
2.6.4 Transformation of E. coli ET12567
200 p,l aliquots of competent cells were transferred into pre-chilled sterile microfuge 
tubes containing 5 -  lOng plasmid DNA or up to 50ng of cosmid DNA. The 
transformation mix was incubated on ice for 15 min. Heat shocked for 5 min in a 37°C 
water bath. Then returned to ice for a further 15 min. 1 ml LB Broth and 20mM Glucose 
was added and the mixture incubated at 37°C for 90 min, inverting the tube to gently mix 
every 20 min. After incubation the transformation mix was plated onto LB agar 
containing the appropriate antibiotics and the plates were incubated overnight at 37°C.
2.6.5 Intergeneric conjugation
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A transformed ET12567 competent cells colony was inoculated into 10 ml LB 
containing kanamycin, chloramphenicol and the antibiotic used to select for the orfT 
containing plasmid. The colony was grown at 37°C, 250 rpm until OD600 of 0.4 to 0.6. 
To reach that optical density usually the cultures would be incubated for 8-10 h. 
Exponentially growing cells were washed twice with an equal volume of LB and then 
gently resuspended in 1/10 volume of LB broth. During the washing steps care must be 
taken when resuspending the cells.
While washing the E. coli cells, for each conjugation approximately 108 Streptomyces 
spores were added to 500 p,l 2 x YT Broth. S. coelicolor spores were germinated at 50°C 
for 10 min then cooled to room temperature. To the activated spores 500p.l washed E. coli 
were added, the mixture was briefly spun down and most of the supernatant was decanted 
off. The pelleted cells were gently resuspended in the residual broth. This conjugation 
mixture was plated out onto SFM agar + lOmM MgC^. After incubation at 30°C for 16 h 
plates were overlaid with 1 ml sterile ddFEO containing nalidixic acid (to inhibit E. coli 
growth) and the appropriate antibiotic selecting for the orfT containing plasmid. Plates 
were incubated at 30°C for a further 3 - 5  days until potential exconjugants could be 
picked and transferred to selective media containing nalidixic acid.
2.7 Isolation of DNA
2.7.1 Plasmid isolation from E. coli
E. coli plasmid DNA was isolated, using DNA binding filters, from overnight liquid 
cultures containing the appropriate antibiotics for plasmid selection. Mini preparations of
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plasmid DNA utilised the WizardPlus SV Minipreps DNA purification system (Promega 
Corp.). Cells from an overnight culture were pelleted at 13000 rpm for 5 min, 
resuspended in 250 pi Resuspension solution and incubated for 5 min at room 
temperature with 250 pi Lysis solution. Gentle inversion mixed these solutions. After 
incubation, 350 pi Neutralisation solution was added, mixed by inversion and the 
resulting suspension was centrifuged at 13000 rpm for 5 min. The cell lysate was 
transferred to a spin column containing a DNA binding matrix. Centrifugation at 13000 
rpm for 1 min allows DNA to be captured on the matrix, it is then washed twice with 750 
and 250 pi Wash buffer, respectively, and the DNA was eluted in the final step in 100 pi 
sterile ddFLO by centrifugation of the spin column, into a sterile microfuge tube, at 
13000 rpm for 2min.
2.7.2 Genomic DNA isolation from Streptomyces
The FastDNA® SPIN Kit for Soil (BIO 101) is designed to rapidly isolate genomic DNA 
by lysing the cells using ceramic and silica particles. Lysing matrix tubes containing 978 
pi Sodium Phosphate Buffer and 122 pi MT Buffer, were filled to 7/8 volume with 
mycelia from 24 h cultures grown on Nutrient agar plates. The tubes were fixed firmly 
into the FastPrep® Instrument and processed for 30 sec at speed 5.5. Then the cell debris 
and lysis matrix were pelleted by centrifugation at 13000 rpm for 30 sec. The supernatant 
containing genomic DNA was transferred to a fresh tube and mixed thoroughly with 250 
pi PPS reagent. The mixture was centrifuged again at 13000 rpm for 5 min, after 
centrifugation the supernatant was transferred to a 15 ml universal tube and mixed with 1 
ml Binding Matrix Suspension. The tube was placed on a rotator (or inverted by hand) for
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2 min. Once the DNA was bound to the matrix it was left to settle for 3 min then 500 (4.1 
of the supernatant were decanted and the remaining solution was mixed and transferred 
into a spin filter, which captures the matrix and the bound DNA. The bound DNA was 
washed with 500 pi SEWS-M and eluted into a fresh catch tube with 50 pi DNase/ 
Pyrogen free water.
2.8 DNA manipulations
2.8.1 Enzyme reactions
Restriction enzymes, T4 DNA ligase, polymerase and calf intestinal alkaline 
phosphatases (CIP) were purchased from New England Biolabs Inc. and Promega Corp. 
The enzymes were used in agreement with the manufacturer’s instructions.
2.8.1.1 Ligations
Prior to ligation, DNA fragments were purified by ethanol precipitation as described by 
(Sambrook et al. 1989) or by using a QIAquick PCR Purification Kit (Qiagen). The DNA 
fragments, in their enzyme reaction mixtures, were mixed with five volumes of Buffer 
PB and applied to QIAquick spin columns. Centrifugation at 13000 rpm for 1 min allows 
DNA to be captured on the matrix; it was then washed twice with 750 pi Buffer PE (wash 
buffer). After an additional centrifugation step at 13000 rpm for 1 min to dry the column, 
the DNA was eluted in the final step in 50 pi sterile ddH20 by centrifugation of the spin 
column, into a sterile eppendorf, at 13000 rpm for 2 min. The ratio of vector to insert 
DNA was estimated, combined at a ratio of 3:1 or 5:1 and ligated overnight at 13°C.
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2.8.2 Visualisation and quantification
2.8.2.1 Agarose gel electrophoresis
Agarose gel electrophoresis was used to analyse nucleic acids. The percentage of agarose 
in the gel depended on the size of the nucleic acid of interest. 0.8% gels are suitable to 
separate restriction digests of plasmid DNA (0.5 to 15Kb), 0.5% gels are used to visualise 
large pieces of DNA, for example, Streptomyces chromosomal DNA. To separate smaller 
PCR products or RNA 1 to 1.5% agarose gels provide better resolution. Standard 100 ml 
gels were routinely prepared as 0.8% (w/v) agarose in 1 x TBE buffer. Samples were 
generally in 20 pi volumes and were mixed with 3 pi Bromophenol blue DNA loading 
dye before being run for 45 -  60 min at 100V. After electrophoresis nucleic acids were 
visualised by staining the gel in ethidium bromide (0.5 pg m l'1) for approximately 30 min 
and destaining in water for 20 min. Nucleic acids were observed using a Biorad 
transilluminator at 254nm.
2.8.2.2 DNA and RNA spectrophotometric quantification
The quality and quantity of nucleic acids may be assayed spectrophotometrically. The 
ratio of A260/ A280 determines the purity of the nucleic acids; in lOmM Tris-Cl (pH 8.5) 
pure DNA has an A26o/ A28o ratio of 1.8 -  2 and in lOmM Tris-Cl (pH 7.5) pure RNA has 
an A260/ A280 ratio of 1.9 -  2.3. The concentration of dsDNA, when A260 = 1, and the path 
length is 1cm, is 50 pg m l'1. The concentration of RNA, when A260 = 1, and the path 
length is 1cm, is 40 pg ml'1.
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2.8.3 Southern hybridisation
2.8.3.1 Preparation of Digoxigenin labelled probes
The transposon specific probe and the XHindlII probe were constructed using the Roche 
dig DNA labelling kit. 5 -  10 pg of Tn5062 DNA was excised as a 3442bp fragment 
from pQM5062 using PvuW and gel purified with a QIAquick Gel Extraction Kit 
(Qiagen). Random priming was then used to amplify labelled Tn5062 DNA. DNA was 
denatured at 100°C for 10 min. It was transferred to ice before the other components of 
the reaction were added. The random priming reaction was incubated overnight at 37°C. 
The XHindlU probe, which associates with the size ladder 'KHindiW was also synthesised 
by random primed labelling.
Standard reaction mixture: 39 pi Denatured DNA
5 pi Hexanucleotide mix
5 pi dig-dNTP labelling mix
1 pi Klenow polymerase
lOng ml'1 each probe was added to the Prehybridisation Solution and prior to use the 
probes were denatured by boiling for 10 min and transferred immediately to ice.
2.8.3.2 Blotting
The chromosomal DNA and the cosmid DNA use as a control were digested with 
appropriate restriction enzymes. After separation by agarose gel electrophoresis the DNA
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was denatured before hybridisation. Firstly the gel was incubated in Denaturing buffer 
with gentle shaking twice for 15 min. Then the gel was washed three time in dT^O and 
immersed in Neutralisation buffer twice for 20 min. Whilst neutralising the gel, a 
nitrocellulose membrane (Hybond-N, Amersham Pharmacia Biotech) was activated by 
soaking in dH20 10 min. Then the membrane and the Whatman paper were soaked in 10 
x SSC for 20 min.
A Stratagene Posiblot Pressure blotter was used to transfer the DNA from the gel onto the 
treated nitrocellulose membrane. The pressure blotter was assembled with Whatman filter 
paper, soaked in 10 x SSC at the bottom, then the membrane (both 1cm bigger than the 
gel in width and height) and on top of this was a plastic mask. The plastic mask contained 
a hole in the centre, 0.5 cm smaller than the gel in width and height. Once positioned the 
gel lies on top of the mask sealing the assembly. Finally a sponge saturated with 10 x 
SSC was positioned over the gel and the apparatus was closed. With 75mmHg pressure 
applied for 90 min the DNA is effectively transferred on to the membrane. Once transfer 
was completed the DNA was fixed to the membrane by baking in an oven at 80°C for 60 
min.
2.8.3.3 Hybridisation
Once the DNA was fixed to the membrane it was wetted in dH20 and rolled inside a 
piece o f nylon mesh. With the DNA facing innermost, it was placed into a hybridisation 
tube (Appligene) and washed with 2 x SSC. The following steps take place in a rotating 
hybridisation oven. The membrane was then prehybridised in 10 ml Prehybridisation
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solution at 42°C. After 60 min the prehybridisation solution was decanted and the 
denatured probe was incubated with the membrane overnight at 42°C. 10 ng ml'1 of each 
probe was added to the Prehybridisation Solution and prior to use, denatured by boiling 
for 10 min and transferred immediately to ice. (After hybridisation the probe may be 
collected and stored at -20°C for reuse.) The following morning the probe was retrieved 
and the membrane was washed. With two five minute washes in Wash Solution I, then 
two stringent washes at 68°C in Wash Solution II, each for 15 min, the membrane was 
ready to be developed.
2.8.3.4 Immunological Detection
The membrane was rinsed for 1 min at room temperature in Buffer I, then for 30 min in 
Prehybridisation buffer. After this, it was briefly washed again in Buffer I before adding 
the antibody solution; 15 ml Buffer I with 3 pi Antidigoxygenin AP (the antibody 
conjugate). This was incubated for 15 min. To remove unbound antibody, the membrane 
was washed twice in Buffer I for 15 min. After these washes in the hybridisation tube, the 
membrane was transferred to a plastic bag where 10 ml of colour solution was added and 
the bag was sealed. To facilitate the colour reaction the membrane was placed in tray in 
the dark, at 37°C. After 1 -  3 h bands were detected and the filter was rinsed in dE^O to 
stop colour reaction.
2.8.4 Polymerase Chain Reaction
Polymerase chain reactions (PCR) were performed by a PTC-200 DNA Engine (M.J. 
Research Inc.) using Vent™ (Exo') DNA polymerase (New England Biolabs Inc.).
57
Oligonucleotides were designed using Primer3 <http://www-genome.wi.mit.edu/cgi- 
bin/primer/primer3_www.cgi> and purchased from MWG-Biotech. A list of primers used 
in this study is shown in Table 2.6. Annealing temperatures were optimised for each pair 
of oligonucleotides used.
Table 2.6 PCR primers
Oligonucleotide Sequence
pBTRev 5' (ggg tag cca gca gca tcc)3'
pTRGFor 5' (cag cct gaa gtg aaa gaa)3'
pBTFor 5' (tcc gtt gtg ggg aaa gtt atc)3'
pTRGRev 5' (att cgt cgc ccg cca taa)3'
Standard PCR were carried out in a total volume of 25 pi in a 0.5 ml thin walled
microfuge tube. A standard mixture added to a sterile 0.5 ml thin walled 
is as follows:
microfuge tube
1 pM Sense primer
1 pM Antisense primer
4 pi dNTP labelling mix (stock concentration 2.5mM)
2.5 pi 10 x Vent Buffer, magnesium free (NEB)
5 — 50 ng Template DNA
1 mM MgSCU
0.5 pi Vent™ (Exo') DNA polymerase
up to 25 pi ddH20
Standard PCR conditions:
Denaturation 95°C for 60 sec 
Annealing variable for 60 sec 
Extension 72°C for 60 sec
2.8.5 DNA sequencing
2.8.5.1 Automated sequencing
Sequencing is a fundamental tool for DNA manipulation, it was used routinely to verify 
the construction of plasmids, integrity of coding sequences and verification of 
mutagenesis reactions. Wizard DNA preparations were quantified spectrophotometrically 
to determine the appropriate amount of template DNA. The right amount of the template 
according to the plasmid length was mixed with ddfhO denatured at 96° C for 1 min, 
cooled on ice and then mixed with DTCS quick start master mix (Beckman Coulter) and 
the desired sequencing primer. Sequencing reactions were amplified by thirty cycles of 
<96° C for 20 sec/ 50° C for 20 sec/ 60° C for 4 min> using a PTC-200 DNA Engine 
(M.J. Research Inc.). Sequencing reactions were separated using the Beckman CEQ 
8000. Table 2.7 shows a list of most commonly used sequencing primers.
Table 2.7 Sequencing primers
Prim er Sequence
1224 5' (cgc cag ggt ttt ccc agt cac gac)3'______
1233
T7 universal primer J 5' (TAATACGACTCACTATAGGG)3'
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LuxAB primer j 5’ (CAGGTGGCTGATAAGTGAGAAGCA) 3’
2.8.6 Site directed mutagenesis
The QuikChange®XL Site-Directed Mutagenesis kit (Stratagene) allows site specific 
mutations to be introduced into plasmids. In this study it was used to introduce a 
restriction site to the transcriptional start of SC05724 and SC05725. Two 
complementary oligonucleotides were designed containing the desired mutation flanked 
by unmodified sequence for each gene (Table 2.8).
Sample reactions were set up as follows:
5 pi 10 x reaction buffer
10 ng dsDNA template
125 ng primer 1
125 ng primer 2
1 pi dNTP mix
3 pi QuikSolution
1 pi PfuTurbo DNA polymerase (2.5U/pl)
up to 50 p 1 ddH20
The new sequence was amplified in a thermal cycler:
95° C 1 min
y 20 cycles
60
95° C 50 sec
60° C 50 sec
68° C 1 min per kb plasmid length
68° C 7 min
After temperature cycling, the reaction was placed on ice for 2 min. 1 pi Dpnl was added 
to the reaction mixture and incubated at 37° C for 60 min to digest the parental (non 
mutated DNA). The newly mutated plasmid was transformed into XL 10-Gold® 
Ultracompetent cells. The cells were thawed on ice and mixed with 2 pi p- 
mercaptoethanol for 10 min on ice. 2 pi Dpnl treated DNA was added to the cells and 
incubated on ice for 30 min. The cells were heat shocked at 42° C for 30 sec and then 
incubated with 0.5 ml LB Broth at 37° C, 225 rpm. After 60 min transformed cells were 
plated onto LB agar with appropriate antibiotic selection for the plasmid vector.
Table 2.8 Mutagenesis prim ers
Mutagenesis prim er_____ Sequence
5' (ccg tac gca acc gag gag aag gga tcc gtg age gtc aat tac g) 
3’
ESATMUT2 5' (cgt aat tga ege tea egg ate cct tct cct egg ttg cgt acg g) 3’
CFPMUT1 5' (ccg ggc gga ccc gcc gtg gtg aca gcc acc ag) 3’
| CFPMUT2 5' (ctg gtg get gtc acc acc egg geg ggt ccg ccc) 3’
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2.9 RNA isolation
The first step before the RNA experiments was to remove all traces of ribonuclease 
(RNase) contamination. Glassware was baked at 240° C overnight. Disposable plastic 
ware was autoclaved twice before use and laboratory equipment and surfaces were dust 
free. RNA was isolated using Qiagen RNeasy® Midi Kits. Streptomyces spores were 
inoculated onto agar plates covered with sterile cellophane discs and at appropriate time 
points cells were harvested into 800 pi Bacterial RNA Protect (Qiagen) and incubated for 
5 min. Mycelia were pelleted at 13000 rpm for 5 min and resuspended into 1 ml TE 
buffer containing 3 mg m l'1 lysozyme. 4 ml Buffer RLT was added and the bacterial 
lysate was centrifuged for 5 min at 4000 rpm to pellet cell debris. The supernatant was 
transferred to a fresh 15 ml tube and 2.8 ml Ethanol was added gently. The sample, 
including any precipitate, was applied to an RNeasy midi column and centrifuged for 5 
min at 4000 rpm. Flow through was discarded and an optional on -  column DNase step 
was incorporated. The silica matrix with RNA bound, was washed once with 2 ml Buffer 
RW1 then 160 pi Buffer RDD (containing 20 pi DNase I stock solution) was incubated 
on the column at room temperature for 15 min (RNase free DNase Kit, Qiagen). A 
second wash step, with 2 ml Buffer RW1 was then centrifuged through the column. 
Finally 2.5 ml Buffer RPE was applied to the column, centrifuged for 5 min at 4000 rpm, 
and the RNeasy column transferred to a fresh 15 ml collection tube. 250 pi RNase free 
water was applied to the column and incubated for 1 min at room temperature. The RNA 
was eluted by centrifugation then aliquoted and stored at -70° C.
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2.10 Reverse- transcriptase RT-PCR experiments.
We used RETROscript® Kit from Ambion. The RT-PCR experiments were performed in 
two stages:
2.10.1 Stage 1.
For each cDNA required one reaction was set up by mixing together:
1-2 pg total RNA
0.1-2 pi o f a 50 pM stock of the gene-specific first-strand primer 
to 12 pi Nuclease-free Water
These reaction components were mixed, spun briefly, and heated for 3 min at 70-85°C. 
The exact temperature was not critical, but 85°C was more appropriate for these targets 
that were high GC. The tubes were removed to ice, spun briefly and replaced back on ice. 
Then the remaining RT components were added:
2 pi 1 OX RT or 10X PCR Buffer 
4 pi dNTP mix 
1 pi RNase Inhibitor 
pi MMLV-RT 
20 pi Final volume
These components were mixed gently and spun briefly. The reactions were then 
incubated at 42^14°C for 1 h. Followed by inactivation of Reverse Transcriptase by
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incubating the tubes at 92°C for 10 min. The cDNA was ready to proceed to the second 
step.
2.10.2 Stage 2. Amplification of this cDNA molecule using different primers.
Two controls were introduced in this step; the first control was the RNA control from the 
previous step and the second was a minus-template PCR that had all the PCR components 
but water was used as template instead of an aliquot of the cDNA.
The reaction mixture was mixed on ice:
1-5 pi RT reaction (from step 1)
5 pi 1 OX PCR buffer
2.5 pi dNTP mix
to 50 pi df^O , nuclease-free water
2.5 pi PCR primers (mixture with 5 pM of each primer)
1-2 U Thermostable DNA Polymerase, mainly dynazyme ((Fynnzymes)
Denature: 94-95°C for 2-4 min
94°C for 20-30 sec 
annealing temp, for 20-3 
72°C for 40 sec to 1 mini 
Final extension: 72°C for 5 min
> 30 cycles
Table 2.9 RT -  PCR primers
Mutagenesis primer Sequence
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A112S1 5' (cat gag cgt cga tta cag) 3’ 
5' (cac ate tgg tcc ate tcc) 3*A112SA1
A113S1 5' (gat tac age gac cag gac) 3’
A113SA1 5' (ctg etc agt tcc gtt gtc) 3’
2.11 Protein isolation.
2.11.1 Native protein isolation.
Spores were inoculated onto SFM agar plates covered with sterile cellophane discs. After 
incubation, cells were scraped off the cellophane disc and placed into 500 pi Lysis buffer 
containing 2 mg ml"1 lysozyme and protease inhibitors and incubated for 5 min at room 
temperature. Samples were sonicated on ice (condition vary but usually four 20 sec bursts 
at 7.5pm). The cell debris was pelleted by centrifugation at 13000 rpm at 4° C and the 
supernatant was transferred to a fresh microfuge tube and stored at -70° C.
2.11.2 Denaturing protein extraction
Spores were inoculated onto agar plates covered with sterile cellophane discs and at 
appropriate time points, cells were harvested into 5 ml Washing buffer. Cells were 
vortexed and pelleted at 4000 rpm, 4° C for 5 min. Pellets were resuspended in 400 pi 
Sonication buffer and sonicated at amplitude of 7.5pm for ten 2 sec bursts. During 
sonication samples were kept cool on ice. Once disrupted the debris was removed by 
centrifugation at 13000 rpm for 15 min at 4° C. The supernatant containing the whole
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cell protein extract is stored in aliquots at -70° C. Prior to SDS-PAGE the samples were 
cleaned and quantified.
2.11.3 Trichloroacetic acid (TCA) protein precipitation from soluble fraction 
Cultures were grown to exponential phase (OD600 0.4 -  0.6) shaking at 250 rpm, 30°C. 
The cells were then pelleted (cells were kept to prepare intracellular fraction see section 
2.11.4) and the supernatant collected in a 50 ml Falcon tube to which a tablet of complete 
inhibitor of protease activity (Roche) was added. TCA solution was added neat at a 
concentration of 1 in 10. The tubes were place on ice and kept overnight in the cold room 
at 4° C. Then the samples were centrifuged for 20 min and the supernatant decanted. The 
precipitate was washed twice with ice-cold acetone and left on the bench until all the 
acetone had evaporated. This pellet was resuspended in sonication buffer. Once the 
sample was resuspended sample loading buffer was added 1:1. Finally the sample was 
quantified with the 2D-Quant kit (Amersham Pharmacia Biotech). Before being analysed, 
the pH of the samples was adjusted in view of the fact that this procedure can sometimes 
produce an acidic pellet.
2.11.4 Denaturing protein extraction from liquid cultures
Cells were pelleted briefly at 4000 rpm to remove any remaining supernatant. Pellets 
were resuspended in equal volume of sonication buffer approximately 400 pi. Cells were 
sonicated at amplitude of 15pm for ten 20 sec bursts. During sonication samples were 
kept cool on ice. Once disrupted the debris was removed by centrifugation at 13000 rpm 
for 15 min at 4° C. The supernatant containing the whole cell protein extract was stored 
in aliquots at -70° C.
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2.12 Protein quantification.
j 2.12.1 Quantification of protein extracts using the BioRad protein assay
The BioRad protein assay allows the rapid measurement of protein concentration in the 
absence of strong alkaline reagents or detergents. This method is based in the classic 
Bradford method. BSA was used as a standard; dilutions of BSA along with protein 
samples were assayed in volumes of 0.8 ml and mixed with 0.2 ml Dye Reagent 
concentrate. After 5 min (but no longer than 60 min) the optical density was measured at 
595nm. A standard curve was plotted of BSA and the concentration of the unknowns was 
read off the standard curve.
2.12.2 Quantification of protein extracts using the 2- D Quant kit.
For protein samples obtained from TCA precipitation the 2D-Quant kit was used to 
determine the protein concentration. A standard curve was prepare according to Table 1 
of the manufacturer’s protocol using the 2 mg/ml Bovine serum albumin (BSA) standard 
solution provided with the kit. Two sets of tubes were prepared containing 2 and 10 pi of 
the samples to be assayed. The useful range of the assay is 0.5-50 pg. 500 pi of 
precipitant solution were added to each tube (including the standard samples). Tubes 
were vortexed briefly and incubated 2-3 min at room temperature. Then 500 pi of co- 
precipitant were added to each tube and mixed briefly by vortexing. The proteins were 
sedimented by centrifuging the tubes at 10 000 x g for 5 min. The tubes were retrieved 
from the microcentrifuge as soon as centrifugation was finished and the supernatant 
decanted (A small pellet should be visible after completion of this step). Without delay 
the tubes were inserted in the microcentrifuge as before, with the cap-hinge and pellet
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facing outward, and centrifuged briefly to bring any remaining liquid to the bottom of the 
tube. A micropipette was used to remove any remaining supernatant until no visible 
liquid was left in the tubes. 100 pi of copper solution and 400 pi o f distilled or de-ionized 
water were added to each tube and vortexed briefly to dissolve the precipitated protein. 1 
ml of working colour reagent was incorporated rapidly to each tube to ensure 
instantaneous mixing. The mixture was inverted a few times and incubated at room 
temperature for 15-20 min. The absorbance of each sample and standard was measured at 
480 nm using water as the reference. The absorbance should be read within 40 min of the 
addition of working colour reagent. A standard curve was generated by plotting the 
absorbance of the standards against the quantity of protein. This standard curve was used 
to determine the protein concentration of the samples.
2.12.3 SDS Polyacrylamide gel electrophoresis
Gels were cast following manufacturer recommendations (BioRad). We separated 
proteins according to size using polyacrylamide. We require a resolving gel; the 
percentage of acrylamide depicts the size of proteins of interest. For example, a 10% gel 
allows the resolution of proteins ranging from 1 6 - 6 8  kD. We used 12% gels for the 
majority of the experiments that provided better resolution for proteins of ca. 10 kDa. 
Proteins enter a stacking gel that ensures that all the samples are concentrated at the 
interface between the stacking and separating gels for an homogeneous run. Generally 
gels were poured and left to polymerise for 1 h or at 4° C overnight. Samples were 
mixed with sample loading buffer and denatured at 95° C for 10 min before loading into 
the stacking gel.
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2.12.4 Visualisation of proteins
To visualise proteins separated by PAGE, two different staining methods were utilised. 
Coomassie blue detects up to 0.1 pg protein. After incubating the gel, gently shaking, for 
4 h in Coomassie blue staining, the gel is destained for a further 4 -  8 h. We also used 
Congo red if the proteins had been transferred to a nylon membrane.
2.12.5 Western blotting
2.12.5.1 Blotting
The protein samples were quantified and mixed with equal amount of sample loading 
buffer. 15- 30 ng of protein were loaded, taking care to use equivalent amounts of each 
sample. 10 ul of Molecular Weight dual marker (Bio-Rad) was also loaded in each 
experiment. The samples were denatured at 95 °C for 5 -  10 min before separation. After 
separation by PAGE the protein gel was soaked in ice-cold transfer buffer (transfer buffer 
was chilled before utilization) for 10- 15 min. The membrane (Hybond-P, Amersham 
Pharmacia Biotech) was activated by soaking in Methanol for 15 sec then, soaked in 
dThO for 5 min and finally for 15 min in transfer buffer. The rest of the components for 
the transfer were also soaked in transfer buffer. Once all the components were ready, the 
assembly was prepared placing the black part of the gel rig on the bench then sponge - 
filter paper - gel - membrane - filter paper and finally sponge. Care was taken to insert the 
assembly in the Mini-Transblot (Bio-Rad) with the correct orientation to ensure the 
transfer of the samples to the membrane. To maintain the transfer cool a cold pack was
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inserted, finally the pre-chilled transfer buffer was poured until the tank was full. The 
power pack was set at 120 V for 1 h.
Once transfer was completed the membrane was incubated with gentle rocking overnight 
with blocking buffer (5% BSA, 10% milk in TBS/0. IT WEEN).
2.12.5.2 Hybridisation
After blocking the membrane was washed 5 times in TBS/Tween and then incubated in 
the primary antibody solution for 60-90 min. Most of the western experiments performed 
did not require incubation with a secondary antibody as the primary antibody was 
enzyme-linked. If the primary antibody was enzyme linked the membrane was washed 5 
times in TBS/Tween after incubation and was then ready for the detection step.
If a secondary antibody was required, then the membrane was washed 5 times in 
TBS/Tween and the secondary antibody was added and the membrane incubated for 60 
min. Finally the membrane was washed 5 times in TBS/Tween and was ready for 
detection.
2.12.5.3 Immunological Detection
The membrane was placed on a tray and 1ml of substrate solution was poured over the 
membrane uniformly taken care to cover the whole membrane surface. After one minute 
incubation, the emission of light would be detected exposing a photographic film to the 
membrane. The photographic film was developed using a Curier machine.
2.13 Bacteriomatch two hybrid system.
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The Bacteriomatch two hybrid Escherichia coli based system was purchased from 
Stratagene and used according to the manufacturer’s instructions. The first step in this 
experiment was to clone the genes in frame into the expression vectors pBT and pTRG; 
cloning was achieved by site directed mutagenesis (Section 2.7.6). Then the expression 
vectors were sequenced to assure that the coding sequences were intact. Then both 
resulting plasmids were co-transformed into an E. coli special strain bought from the kit 
manufacturer. Co-transformants were grown in plates selecting for the resistant marker of 
both plasmids. Rigorous controls were set up to avoid any possible faults in the test 
interaction.
2.14 Preparation of samples for light and fluorescent microscopy.
Cultures for light and fluorescence microscopy were set up by introducing a sterile 
coverslip at a 45 angle into the agar plate. Four pi of spore suspension was then 
inoculated in the acute angle along the glass surface (Chater 1972). Coverslips were 
removed after 2-A d incubation at 30 C and cells on the coverslip surface were stained 
with propidium iodide for nucleoids, and/ or stained for the cell wall, with fluorescein- 
conjugated wheat germ agglutinin (Fluo-WGA) after fixation, treatment with lysozyme 
and blocking with BSA (Schwedock et al. 1997) fluorescent reagents were obtained from 
Molecular Probes. The samples were then washed five times with PBS (Sambrook et a l 
1989), and mounted for microscopy in PBS containing 50% glycerol. Occasionally we 
grew the cultures normally and the collected the samples by taking surface impressions of 
two to five days old plates. Hyphae were fixed in methanol and stained with propidium 
iodide if the nucleic acid content was to be observed or fixed with glutaraldehyde and
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stained with propidium iodide and fluorescent wheat germ agglutinin as described by 
(Flardh et al. 1999) and mounted in 40% glycerol (Kieser 2000). Samples were studied 
using a Nikon Eclipse E600 epifluorescent microscope with a standard FITC filter set and 
images were captured using a RS Photometries digital camera. The same microscopic 
slide could be analysed with the red DNA filter to observed nucleoids or the green filter if 
we required to visualized the cell wall.
2.14.1 Measurement of septum compartments from micrographs.
A statistical analysis of the septum length was performed on cultures of esxA and esxB 
mutants. The program used to measured the compartment length was Scion scientific 
available from http://www.scioncorp.com/. Before the program was used the scale was 
set for one unit to be 15.1878 micrometers. In the ANALYSE tab we chose the perimeter 
length option. Each measurement was recorded when pressing CTRL + 1. When it was 
require to start a new set of results (a different hypha was been analysed) CTRL + 3 was 
depressed. The data was recorded in Excel spreadsheet and each column represented all 
the measurements taken from a single hypha. With the data obtained a histogram was 
constructed for each mutant and the wild-type strain.
2.15 Luciferase assays
2.15.1 Solid media
96 well culture plates (Greiner bio-one) were used to quantify luxAB expression assays. 
300 pi agar was pipetted into each well and 2 pi spore suspension was aliquoted into each 
well. Cultures were then incubated at 30° C. At appropriate time intervals plates were
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exposed to N-decanal; approximately 1 ml N-decanal was pipetted onto filter paper cut to 
the size of the plate. The saturated paper was laid on top of the plate for 1 min. This 
exposed the cultures to the volatile aldehyde and allowed the luciferase enzyme to 
undertake the oxidation of N-Decanal. The resulting luminescence (arbitrary units) was 
measured with Lucyl Luminometer (LabTech). On each plate, samples were measured in 
triplicate and experiments were repeated at least twice to ensure reproducibility.
2.15.2 Liquid media
96 well culture plates (Corning) were used to quantify optical density and luxAB 
expression. At appropriate time intervals 1 ml of each flask was extracted in sterile 
conditions. The flask was then replaced in the 30 C shaker. To the 1 ml of the culture 7 pi 
of N-Decanal was added and the contents of tube mixed. 250 pi of this mixture would be 
inoculated into 96 well culture plates. The plate was then ready to be analysed; firstly the 
resulting luminescence (arbitrary units) was measured and then the optical density of the 
suspension at 610 n.m. to evaluate the growth rate. Both measurements were carried out 
with Lucyl Luminometer (LabTech). On each plate, samples were measured in triplicate 
and experiments were repeated twice to ensure reproducibility.
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C h a p t e r  III 
PHENOTYPIC ANALYSIS OF esxAB 
MUTANTS OF STREPTOMYCES COELICOLOR
Chapter III Phenotypic analysis of esxAB mutants of S. coelicolor.
3.1 Introduction.
My aim was to investigate the function of the esxl locus of S. coelicolor. This is 
orthologous with the esxl locus which is critical to the virulence of pathogenic 
mycobacterium in the host. The locus is the key to latency in Mycobacterium tuberculosis. 
The most important genes of the locus are esxB and esxA. The orthologues of these genes 
in S. coelicolor are SC05724 and SC05725. This chapter explains the construction and 
characterization of mutants of the esxAB operon of S. coelicolor.
3.2 Disruption of esxA and esxB in Streptomyces coelicolor.
A complete archived mutant library is being constructed by in vitro transposon 
mutagenesis using the provision of an ordered cosmid library (Redenbach M 1996) and 
the information provided by the genome sequencing project o f the 8,667,507 base pair 
genome sequence of S. coelicolor A3(2) (Bentley et a l 2002).
The first step of the procedure was to incubate cosmid SC3C3 with Tn5062 and 
transposase. E. coli was electroporated with 1 pi of the in vitro transposition reaction. 
The subsequent steps have been automated: 192 apramycin-resistant clones were 
randomly picked and transferred to growth blocks; then cosmid isolation, DNA 
quantification and DNA sequencing were carried out by a robot and an automated DNA 
sequencer. The DNA sequence files were processed to identify the exact site of each 
Tn5062 insertion using Transposon Express software, developed in our laboratory by 
Gareth Hughes (Herron et al 2004). These data were then incorporated into ScoDB
fhttD://streptomyces.org.uk/S.coelicolor/index.htmO at the John Innes Centre.
There is only one Tn5062 insertion per mutated cosmid molecule. From 192 cosmid 
clones we obtained one insertion labelled as SC3C3.1.H11 and SC3C3.1.E07 in genes 
SC05724 and SC05725 respectively, in each of the desired genes.(Bishop et al. 2004) 
Intergeneric conjugations were performed to transfer the mutated cosmids into S. 
coelicolor A3(2) M l45. The exconjugants were selected on the basis of the antibiotic 
resistant marker on the Tn5062 transposon that contains an apramycin cassette. Double 
crossovers were selected because they lack the kanamycin resistance cassette of the 
cosmid backbone and were therefore kanamycin sensitive, apramycin resistant.
For SC05724, five double exconjugants were obtained and the mutation was confirmed 
by Southern hybridization. From these five I worked with the three that were most 
phenotypically similar to each other. There were eight double crossover mutants isolated 
for SC05725 the mutation was confirmed by Southern hybridization for the six clones 
that had an identical phenotype. The mutants DC5724 and DC5725, were called esxA and 
esxB, respectively.
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Figure 3.1 Diagrammatic representation of the Southern blot experiment.
DC5724 
(esxB)
DC5 725
(esxA) Sal 1 Sal 1 Sal 1
SCO5 722 
blclB
SCO5 724 
SCO5725
SCO5726
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Figure 3.2 DC5725 Southern blot experiment.
Lane 1, lambda Hindlll, Lane 3, cosmid DNA control, lanes 4-9, exconjugants.
4.3 kb 3.041 kb
2.3 kb
1.114 kb
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Figure 3.3 DC5724 Southern blot experiment
Lane 1, cosmid DNA control; Lanes 2-6, exconjugants; Lane 7, lambda HindlU 
molecular size marker.
3.909 kb
0.853 kb
1 2 3 4 5 6 7
4.3 kb
2.3 kb 
2.0 kb
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3.3 Phenotypic analysis of the esxAB mutants.
Intergeneric conjugation yielded several clones in which the allelic replacement had 
occurred. For the SC05724 mutation, I isolated five independent clones of which three 
shared a similar phenotype. For the SC05725 mutation, I isolated eight independent 
clones of which six shared a similar phenotype. Having isolated several independent 
clones, I then validated the allelic replacement by Southern hybridization. The clones 
were patched onto a nutrient agar plate and incubated overnight. 100 mg of mycelium 
was scraped off and DNA extracted using a Fast Prep Soil DNA kit (Q.BIOgene). The 
DNA was restricted with an enzyme predicted to cut once within Tn5062 and at defined 
distances in either flanking sequence. As a positive control, the relevant cosmid DNA 
was restricted with the same enzyme. The samples were electrophoresed and blotted. The 
membrane was then hybridised with a digoxigenin labelled Tn5062 3442 bp PvuII 
fragment probe. The probe hybridised to the same two bands in the cosmid and genomic 
DNA lanes, as predicted (Figure 3.2; 3.3)
Colonies were patched onto MS agar without selection for two generations of growth 
before being phenotypically analysed (Figure 3.4). The mutants displayed a 
developmental phenotype. They develop slower that the parental strain. The aerial 
hyphae appears at the same time than in the wild -type but then there is a time lapse until 
those aerial hyphae reach maturity. esxAB mutants reached maturity after 7 -8  days 
incubation. They required up to 2-3 extra days more than the wild- type to develop. Even 
when they reached maturity they had a decreased number of spore chains as
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demonstrated by visualizing microscopic slides at 40x -60x magnification and comparing 
mutant fields to wild- type fields.
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Figure 3.4. Photograph of the mutants after 48 h of growth on MS media without
selection.
a, esxA mutant clones, top patch is M l45 then clockwise clones 1-4 ;b, top patch is M l45 
then clockwise esxA mutant clones 5-8 ;c, top patch is M l45 then clockwise esxB 
mutant clones 1 -3.
M145
M145
M145
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3.4 Microscopic analysis of S. coelicolor esxA and esxB on solid media.
Cultures of the esxA and esxB mutants of S. coelicolor for light and fluorescence 
microscopy were set up by inserting a sterile coverslip at a 45 angle into MS agar and 
inoculating in the acute angle along the glass surface (Chater 1972). Coverslips were 
removed after 48 h incubation at 30°C and cells on the coverslip surface were stained 
with propidium iodide for nucleoids, and stained for the cell wall, with fluorescein- 
conjugated wheat germ agglutinin (Fluo-WGA) (Section 2.14). Cytological examination 
of the mutants revealed several aspects of their morphology. Firstly the most noticeable 
characteristic was the irregularity in the spore compartment sizes. In the wild- type 
mature hyphae there is the occurrence of some irregularities in the compartments but the 
frequency is very low. The norm is that the length of the compartment be between 1.5 -  
1.7 jam. In the esxAB mutants the compartment size irregularities are much more frequent. 
The DNA of the apical compartment of the aerial hyphae needs to be segregated into 
unigenomic units in a process that is not clearly understood. There is limited knowledge 
about which step goes first. The DNA inside each compartment was visualized by the 
propidium iodide staining. In the wild- type the genetic material seems totally 
concentrated and segregated so that the DNA inside each cell appears as an oval-rounded 
sphere. The esxAB mutants DNA differ from the wild- type’s in that it appears elongated 
as if the DNA is not completely segregated. In the esxAB mutants there were also a 
considerable number of ghost compartments devoid of DNA. To be able to analyse these 
differences quantitatively I decided to measure the interseptal distances (Section 3.5.1).
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Figure 3.5 Micrographs of the M145 strain at 100 times magnification.
In these micrographs (a-f) the regularity in the septation of the parental strain is evident. 
The DNA is completely segregated and each spore compartment contains a single copy 
of the genome with all the compartments looking identical. Note that Fluo-WGA dye 
have the ability to only bind to nascent peptidoglycan unit and therefore mature spore 
chains may not appear in the green channel.
a b
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Figure 3.6 M icrographs of the esxA m utant at 48 h time point viewed at 100 times 
magnification.
These micrographs (a-d) clearly show irregularities in the septation of the esxA mutant. 
The DNA is segregated. Each spore compartment does not seem identical however you 
look at the Fluo-WGA staining o f  the cell wall or the propidium iodide DNA staining. 
The arrows indicate irregularities.
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Figure 3.7 Micrographs of the esxB mutant strain at 48 h of growth viewed at 100 
times magnification.
These micrographs (a-d) clearly show irregularities in the septation of the esxB mutant. 
The DNA is segregated. Each spore compartment does not seem identical however you 
look at the Fluo-WGA staining of the cell wall or the propidium iodide DNA staining. 
The arrows indicate irregularities.
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3.4.1 Statistical analysis of the spore compartment length in esxA and esxB mutants. 
Microscopic analysis of the esxA and esxB mutants revealed that there was a slight 
variation in the pattern of septation. Three strains were analysed: The wild-type, esxA 
mutant and esxB mutant microscopic samples were taken at 48 h and stained with Fluo- 
WGA. The total number of compartments counted was: for the wild-type 415 
compartments, esxA mutant 741 compartments and esxB mutant 489 compartments. The 
program used to measured the interseptal distance was Scion scientific available from 
http://www.scioncorp.com/. With the data obtained a histogram was constructed for each 
mutant and the wild-type strain. The data corroborated my visual observations. There 
seem to be irregularities in the size of the interseptal space. But the results provided me 
with further information about the irregularities.
In the wild-type (figure 3.9) the mode value was 1.2 pm. The total number of interseptal 
compartments of size 1.2 pm was 67 from a total of 415 that make up a 16 per cent of the 
total. The histogram shows a normal distribution centred around value 1.2 pm and then 
there is a small peak distributed between 2.1 and 2.7 pm. The normal interseptal space 
measured between 1.1 and 1.4 pm. The percentage of compartments that falls within the 
normal distribution is 97%. The small population constitutes only 2% of the whole. This 
indicates that 97% of the compartments fall within a normal distribution.
In the esxA mutant the histogram (figure 3.10) described two distinct peaks that seem to 
represent two populations. The mode value was 1.3 pm and for this particular interseptal 
size there were 84 events. Then there was another peak of 0.3 pm with 34 events. From a
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total of 741 the peak o f 1.3 pm constitutes an 11 per cent of the total and the peak of 0.3 
pm represents a 4.6 per cent of the total. This result meant that in esxA the majority of the 
compartments were slightly bigger than in the wild-type and also it meant that there were 
a large number of smaller sized compartments below the average standard measurement. 
The percentage of compartments distributed between (0.1-0.5 pm) was 7 per cent. The 
percentage of compartments distributed between 0.6 and 2.5 pm was 92 per cent of the 
total.
In esxB mutant the histogram (figure 3.10) also showed two distinct peaks that seem to 
represent two populations of a different nature from esxA. The mode value was of 1.4 pm 
with 42 events. Then there was another peak of 2.4-2.5 pm with 12 events. From a total 
of 489 the peak of 1.4 pm constitutes an 8.6 per cent of the total and the peak of 2.4-2.5 
pm represents a 2.4 per cent of the total. This result meant that in esxB the majority of the 
compartments were slightly bigger than in the wild-type and also it meant that there were 
a large number of bigger sized compartments above the average standard measurement. . 
The percentage of compartments distributed between (2.2-2.9) was 9 per cent. The 
percentage of compartments distributed between (0.6-2.5) constitutes 90 per cent of the 
total.
I decided to use a t-Test for independent samples because the measures had a relatively 
normal distribution, and although I have more than two conditions, I intended to compare 
the conditions in pairs (the data obtained from each esxA and esxB mutants with the wild- 
type individually). The data was tested for the differences between the means. The idea
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was to prove that the differences between the esxAB mutants and the wild- type did not 
arise by chance.
The differences between esxA and the wild- type were significant. From table E, t = 1.960 
at the 0.05 level of significance (p= 5 per cent) with oo degrees of freedom. The observed 
value of t was 2.79 that is numerically greater than 1.960. Therefore we can assume that 
the absence of the gene has an effect on the length of the septa.
The differences between esxB and the wild- type were also significant. From table E, t = 
1.960 at the 0.05 level of significance (p= 5 per cent) with oo degrees of freedom. The 
observed value of t was 8.86 that is numerically greater than 1.960. Therefore we can 
assume that the absence of the gene has an effect on the length of the septa. The raw data 
for these calculations and the table for the t-Test value can be found in the Appendix.
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Figure 3.8 Histogram representing the frequency of different sized septa in the wild- 
type.
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Figure 3.9 Histogram representing the frequency of different sized septa in the esxB.
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Figure 3.10 Histogram representing the frequency of different sized septa in the
esxA mutant.
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3.4.2 Atomic force microscopy (AFM) analysis of esxAB mutants spore morphology. 
Atomic force microscopy (AFM) is a new imaging method discovered in 1986. Like 
other scanning probe microscopes, AFM utilises a sharp probe moving over the surface 
of a sample in a raster scan. In the case of the AFM, the probe is a tip on the end of a 
cantilever which bends in response to the force between the tip and the sample. I used 
this new imaging technique to visualize the surface of the wild- type and esxAB mutants 
and examine the differences among them (figure 3.12; 3.13 and 3.14). The results from 
the AFM showed striking differences between the parental strain and the mutants. The 
wild- type mature spores appeared smooth and full- bodied, while on the other hand the 
esxAB mutant micrographs showed sporulating hyphae that seem crumpled as if the 
spores were dehydrating. esxAB spores seem slightly thinner and the structure of the 
molecules that coat the hyphae seem altered somehow accumulating numerous amounts 
of molecules at septa interface. The differences appear to be due to less separation of the 
spores following cell division in the mutants. In the wild- type the cell wall is extensively 
remodelled at each division site and the individual spores then round-up. This does not 
appear to happen at 48 h in the mutants.
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Figure 3.11 AFM m icrograph of the wild-type after 48 h of growth on MS media 
without selection.
The surface of the spores in the parental strain M l45 appears spherical all along the 
surface. There is one concavity in each spore only on one side of the spore.
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Figure 3.12 AFM micrograph of the esxA m utant after 48 h of growth on MS media 
without selection.
The esxA mutant spores appear wrinkled and crumpled.
StlSIP
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Figure 3.13 AFM micrograph of the esxB mutant after 48 h of growth on MS media 
without selection.
The esxB mutant spores resemble the phenotype of the esxA mutant being totally creased 
on the entire surface o f  the mature sporulating hyphae.
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3.5 Morphological analysis of the complemented esxA and esxB mutant on solid 
media.
The final experiment to conclude the gene knock-outs were responsible for the phenotype 
was to complement the mutation. The mutant cosmid library facilitates the cloning of 
genes for complementation. By selecting a Tn5062 insertion in a region flanking the gene 
of interest and choosing suitable restriction sites, the gene can be excised and cloned 
together with aac3(IV), permitting positive selection (apramycin-resistance). The gene of 
interest was sub cloned into an integrative plasmid (section 3.3) for use in the 
complementation experiment.
3.5.1. Construction of an integrative plasmid containing Streptomyces coelicolor esxA 
and esxB genes.
Plasmid pSAHISl was made using pSET152 BamH\- EcoKV as the plasmid backbone, 
ligated to pSAXhoI. Plasmid pSAXhoI is a derivative of pSA2 with an in-frame Xhol site 
at the end of esxA coding sequence (introduced by site -  directed mutagenesis see 
Chapter 2). pSAXhoI digested BamHl-Xhol was ligated to both Xho\-Sma\ fragment 
from pET26S(+) containing a Histidine tagged and the pSET152 as the plasmid backbone 
(Figure 3.14). All ligated in this order, purified plasmids were subject to restriction 
analysis and from those containing the insert in the desired orientation one was selected 
for sequencing and further steps. The plasmid pSAHISl (Chapter 2), was modified to be 
able to complement the mutants esxA and esxB that were apramycin resistant. The 
apramycin cassette was replaced by the hygromycin cassette to create pSAHIS2 (Chapter 
2). Both plasmids contain esxA carboxy terminal Histidine tagged and esxB coding
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sequences under the control of their native promoter. Figure 3.15 describes the cloning 
procedure.
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Figure 3.14 Construction of an integrative plasmid pSAHISl containing esxA 
carboxy terminal histidine tagged and esxB genes.
Plasmid pSAHISl was made using pSET152 BamU\- EcoBN as the plasmid backbone, 
ligated to pSAXhoI (derivative of pSA2 with an in-frame Xho\ site at the end of esxA 
coding sequence) digested BamWl-Xhol and Xhol-Smal fragment from pET26S(+) 
containing the Histidine tag. All fragments were ligated in this order.
Bam HI (5445) 
PstI (543iX  
H indiiI (5430) \  {
/  EcoR V  (5490) 
E coR l (5500)
{ SacI (1070)
XhoJ (1470)SSOObp
-SacI 0730)H indi!t (3780)
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Figure 3.15 Construction of a pSAHIS2 hygromycin resistant integrative plasmid 
containing esxA carboxy terminal histidine tagged.
Plasmid pSAHISl (Chapter 2), was modified to be able to complement the mutants esxA 
and esxB that were apramycin resistant. The apramycin cassette was replaced by the 
hygromycin cassette to create pSAHIS2.
B a m H I(l)
Xho (1208)
H is lag
pSAHISlHindlD (5980)
terminal repeats
7708bp
EcolCRI (3200)
EcolCRl (39(X1)
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After incubation for 5 days to allow aerial development, esxA/pSAHIS2 exhibits a wild 
type phenotype, developing a grey aerial mycelium, confirming that S. coelicolor esxA 
phenotype is solely due to the disrupted esxA and esxB genes. This complementation 
restores the native dark grey pigmentation of the wild-type. The strains that contain the 
pSH152 integrative plasmid always look slightly lighter than the complemented strain. 
To account for this difference M l45/ pSH152 was used as a control.
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Figure 3.16 Photograph of the complemented esxA mutants after 48 h of growth on
MS media without selection.
esxA mutant clones, top patch are M l45 then anti-clockwise esxA mutant, then five 
pSAHIS2/cs;c# clones.
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Figure 3.17 Photograph of the complemented esxB mutant after 48 h of growth on
MS media without selection.
esxB mutant clones, top patch is M l45 then anti-clockwise esxB mutant, then five 
pSAHIS2/e.sxS clones.
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3.6 Microscopic analysis of the complemented esxAB  mutants 
The analysis of the complemented mutant was carried out exactly as for the mutant 
strains. Most of the analysis was performed at 48 h of growth. The microscopic 
observations correlate with the macroscopical results and yielded the expected results. 
The complemented esxA mutant showed an increased regularity in the shape and sizes of 
the spore chains. Also there seem to be an increase in the number of spore chains, this 
being apparent because of the increased amount of spore chains when carrying out the 
microscopy analysis. The analysis was completed by measuring the septa and the data 
analysis and histograms can be found in the Appendix in the complementation folder.
I l l
Figure 3.18 Micrograph of the complemented esxA mutant after 48 h of growth on
MS media without selection
.*■ " ‘ " 
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Figure 3.19 Photograph of the complemented esxB m utant after 48 h of growth on 
MS media without selection.
3.7 Conclusion.
These results constitute the first evidence in Streptomyces coelicolor of the esxAB being 
functional and possibly having a role in morphogenesis of the bacteria. Mutants of esxA 
and esxB display a delay whi phenotype and have a defect in the spore maturation phase 
of growth. Microscopical studies showed that the esxA and esxB mutants have in general 
greater sized compartments than the wild-type. The esxA mutant also had a population of 
compartments that were smaller in size. On the other hand the esxB mutant had a 
population of compartments that were larger in size about double the size of a standard 
wild-type compartment. The perimeter encircling the DNA usually coincides with the 
volume of the DNA molecule that it encloses. Both the esxA and esxB mutants were 
complemented with the pSAHIS2 plasmid demonstrating that their phenotypes were 
solely due to the disruption mutations in their respective genes.
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CHAPTER IV 
EXPRESSION STUDIES OF STREPTOMYCES
COELICOLOR esxAB.
Chapter IV. Expression studies of Streptomyces coelicolor esxAB.
4.1 Introduction.
In this chapter I discuss the analysis of the expression of esxAB. Firstly I confirmed by 
reverse transcriptase-PCR (RT-PCR) that the genes are co-transcribed and therefore 
constitute an operon. This is important to corroborate that the genes have a common 
purpose in the bacteria as functionally related coding frames are usually grouped 
together. Then I constructed a plasmid containing the promoter region of the genes. I 
fused this region to the luxAB cassette to assess the activity o f the promoters. I 
performed these experiments in the wild-type background and in the bldB mutant 
background. I constructed the bldB mutant using the hygromycin resistant transposon 
Tn5066.
4.2 Co-expression of esxAB  in S. coelicolor.
The ORFs encoding the proteins, esxB and esxA, are 374 and 311 bp, respectively, 
separated by a 37-bp DNA region (Fig. 4.1). The short intergenic space suggests that 
these two genes may be transcribed as one mRNA unit. This was investigated by RT- 
PCR with RNA isolated from cultures of S. coelicolor. A specific primer set was 
designed so that the forward primer (A112 SI-primer) carried a sequence from the 5' 
region of esxB and the reverse primer (A112SA1-primer) was 715 bp downstream and 
had a sequence complementary to that of the 3' terminus o f esxA (see Appendix for 
sequences ). RNA was isolated from S. coelicolor after growth for 48 h in broth 
culture; prior to cDNA synthesis, RNA was treated with RNase-free DNase I (Roche) 
at 37°C for 20 min. The experiment had two steps: Reverse transcription was carried 
out in with the reverse primer, and the resulting products were amplified by PCR. A 
cDNA species was obtained from this RNA SI obtained by amplifying using the
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forward primer A112S1 and reverse primer A112AS1. The PCR reaction was carried 
out using the SI cDNA species. A single amplicon of the expected size 715 bp was 
obtained (Fig. 4.2), and it was confirmed by nucleotide sequencing that the amplicon 
carried the esxAB gene pair. No amplicon was obtained in the absence o f reverse 
transcription. This experiment was carried out in duplicate obtaining the same result 
on both experiments.
4.3 Co-expression of esxA, esxB and SCOS726 in S. coelicolor.
There was a lack o f homology information about the SC05726  gene. The coding 
sequence is not homologous to any sequence described in the literature. We decided 
to attempt to investigate whether the gene was also co-transcribed with the esxAB 
pair. The ORFs encoding the proteins, esxA and SC05726, are 311 and 465 bp, 
respectively, separated by a 120-bp DNA region (Fig. 4.1). The intergenic space 
suggests that these two genes may or not be transcribed as one mRNA unit. This was 
investigated by RT-PCR with RNA isolated from cultures of S. coelicolor. A specific 
primer set was designed so that the forward primer (A113 SI-primer) carried a sequence 
from the 5' region of esxB and the reverse primer (A113SA1-primer) was 1300 bp 
downstream and had a sequence complementary to that of the 3' terminus of SC05726  
(Chapter 2). RNA was isolated from S. coelicolor after growth for 48 h in broth 
culture; prior to cDNA synthesis, RNA was treated with RNase-free DNase I (Roche) 
at 37°C for 20 min. The experiment had two steps: Reverse transcription was carried 
out in with the reverse primer, and the resulting products were amplified by PCR. A 
cDNA specie was obtained from this RNA, S2 obtained by amplifying using the 
forward primer A113S1 and reverse primer A113AS1. The PCR reaction was carried 
out using the S2 cDNA species. No amplicon was obtained for S2 cDNA, the positive
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controls using DNA from plasmid pSA2633 and from M l45 strain genomic DNA 
diluted 1:10 both produced a band of 1300 bp. No amplicon was obtained in the 
absence o f reverse transcription. This experiment was carried out in duplicate 
obtaining the same result on both experiments. The results suggested that the genes 
were not co-transcribed as depicted in figure 4.3
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Figure 4.1. Diagram representing the positions of the primers to be able to 
evaluate co-transcription of esxAB and SC05726.
a, position of primers A112S1, A113S1; b, position of primer A112AS1; c, position of 
primer A113AS1. Note that 715 bp is the distance between the forward and reverse 
primers.
_, bldB esxB esxA SCO5726 SCO5727
3 ’
 ^ 'yr
A112AS1
,715 bp
A112S1 #
A113S1 1300 bp A113AS1
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Figure 4.2. RT-PCR experiment to demonstrate co-expression of esxA and esxB.
The 1 -kb ladder indicates the sizes at both sides o f the gel. Lanes 2 and 3, results of 
amplifying PCR with water and RNA as a template. Lanes 4 and 5 positive control 
wild-type DNA and SI cDNA, respectively.
' ■ i t .  * ££•'* ." , M  t- ' S.?yi
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Figure 4.3. RT-PCR experim ent to dem onstrate co-expression of esxA , esxB  and 
SC05726.
Lane 1, 1 kb NEB ladder. Lanes 2, 3 and 4, result o f amplifying PCR with water, 
RNA and S2 cDNA as a template, respectively. Lanes 5 and 6 positive controls: wild- 
type and plasmid pSA2633 DNA, respectively. Lane 7 lambda HindlU ladder.
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4.4 Expression studies using a transcriptional fusion to the luciferase cassette.
4.4.1 Expression studies in the wild type background.
Luciferase was preferred as the reporter gene because of its sensitivity and the 
possibility to perform the experiments in microtitre plates, allowing the use o f various 
growth media and also the possibility to simultaneously measure growth and activity 
to normalise results.
Plasmid pSAluxl was constructed using pRlux86 (apramycin resistant). pRlux86 was 
used as a negative control for the totality of the luciferase experiments. The plasmid 
backbone pRlux86 was restricted with BamHl. A  BamHl/Bglll 559 bp fragment from 
plasmid pSA2 was purified from an agarose gel and ethanol precipitated. This 
fragment contains the totality of the intergenic region between bldB and esxB, and 23 
codons of esxB coding sequence. This way I could ensure that the promoter o f esxAB 
would be confined in that 559 bp fragment. The BamHl/Bglll 559 bp fragment from 
plasmid pSA2 was ligated to pRlux86 restricted with BamHl. The ligation reaction 
was electroporated into E. coli JM109 electrocompetent cells and plated on LB 
apramycin plates. Colonies carrying recombinant plasmids were grown in liquid LB 
apramycin and the cultures used for plasmid extraction. After restriction enzyme 
analysis, plasmids containing inserts were sequenced to confirm they contained the 
correct insert in the right orientation. The native promoter o f the genes was placed in­
frame with luciferase genes luxABE. The cloning procedure is described in figure 4.4.
Plasmids pSAluxl and pRlux86 were introduced by intergeneric conjugation into S. 
coelicolor M l45. For each of the strains, three colonies from each conjugation were 
selected for further studies. The preliminary experiments were carried out in solid
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media and those were followed by more in-depth studies in liquid conditions using a 
variety o f growth media. The procedure for the lux experiments is described in section 
2.15.2.
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Figure 4.4 Construction of an integrative plasmid containing the putative esxAB 
promoter fused to the luxAB cassette.
Plasmid pSAluxl was constructed using pRlux86 (apramycin resistant). A 
BamHl/Bglll 559 bp fragment from plasmid pSA2, that contained the totality of the 
intergenic region between bldB and esxB, and 23 codons of esxB coding sequence was 
cloned to ensure that the promoter of esxAB would be confined in that 559 bp 
fragment. The BamHl/Bglll 559 bp fragment from plasmid pSA2 was ligated to 
pRlux86 restricted with BamHl.
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4.4.1.1 Analysis o f the esxAB promoter in solid media
The analysis o f the activity of the promoter in the wild-type was performed by 
growing the strain on MS media. Spore suspensions from Streptomyces coelicolor 
M l45 containing pSAluxl or pRlux86 were grown on MS solid media in 96 well 
black assay microplates, as illustrated in (Chapter 2). The medium was selected 
because of the results o f the phenotypic analysis of the mutants (Chapter 3).
Luminescence was measured at 18, 24 and 48 h time points. For every biological 
replica, data collected were averaged and standard deviations determined. The 
promoter expression was plotted to be able to examine how the expression behaved as 
the bacterium developed.
This solid media experiment showed that in MS media the promoter reached its 
maximum expression at 24 hrs (Figure 4.5). Then the expression started to decreased, 
this preliminary experiment provided me with some clues about the pattern of 
expression of the promoter coinciding the maximum expression with the onset of 
aerial development.
4.4.1.2 Analysis o f the esxAB promoter in liquid media
The next step was to assess the expression in more detail. I decided to utilize liquid 
cultures because they allow the growth rate to be accurately calculated and therefore 
the amount o f luminescence could be corrected according to the growth of the culture. 
Using liquid cultures I analysed the expression of the esxAB promoter during 
vegetative growth as S. coelicolor does not sporulate in liquid culture. Strains of 
Streptomyces coelicolor M l45 containing pSAluxl or pRlux86 were grown on MS,
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NA and TSB liquid media in sterile flasks containing stainless steel springs. At the 
chosen time point 1 ml o f culture of each strain was withdrawn out o f the flask and 
pipetted in triplicate into a 96 well black assay translucent bottom microplates in an 
orderly fashion. OD450 was then measured followed by the estimation of luminescence 
after the addition o f substrate N-Decanal, as described (Chapter 2).
In the first analysis I used different growth media to evaluate the development in 
different environments. The results from these experiments suggested that the 
promoter is most active during growth in tryptone soy broth media (TSB) (Figure 
4.8). When the expression was studied in conjunction with the growth rate, additional 
insight into the behaviour of the esxAB promoter was gained. In NB the promoter 
activity was high from the 16 h to the 24 h time point. The expression became very 
low at the 30 h time point and after slowly decreased until the 72 h time point (Figure 
4.6). In R5 the promoter activity was high at the 16 h time point and plummeted to 
zero in the 24 h time point and continue at this basal level of expression until 72 h 
time point (Figure 4.7). The TSB plot (ratio of promoter activity versus OD) was 
identical to the R5 curve but the activity of the promoter reached the 100 value 
(Figure 4.8).
The following experiments were performed growing the strains on TSB media 
increasing the number of time points. I also carried out the experiments using cultures 
grown from a pre-culture and directly from the spore suspensions in parallel to 
determine whether the promoter was also active during germination. To consider the 
growth rate I also measured the optical density at 450 nm and calculated the ratio 
between the luminescence and growth rate.
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The first noticeable difference between the two ways of inoculation was that the 
growth not surprisingly was slower when the cultures were inoculated straight from 
the spore suspensions. When plotting the OD alongside luminescence, the plots 
showed significant differences: when the cultures are grown from a pre- culture 
(Figure 4.9), the activity is very high from the 5 h to the 8 h time point. After the 8 h 
time point promoter activity decreases to very low levels. Finally the activity becomes 
nil 42 h. On the other hand if the cultures are grown from spore suspensions the 
activity of the promoter is nil until the 13 h time point (Figure 4.10). The activity is 
upregulated progressively until the 28 h time point and decreases but continue to be 
high through the 30 h time point and finally becomes nil at the 42 h time. Presumably 
this is due to the time lag in germination before exponential growth is achieved. To 
summarise, the esxAB promoter was active at the onset of aerial development and then 
the activity decreased over time indicating that it may be involved in a role on aerial 
development.
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Figure 4.5. Analysis of the activity of the esxAB promoter during growth on MS 
solid agar using a transcriptional fusion to the luxAB cassette.
The red arrow indicates the onset of aerial growth.
Expression of the esxAB promoter in solid MS.
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Figure 4.6 Ratio of the promoter activity versus optical density in nutrient broth.
Ratio o f  the luminescence versus O.D. 450 nm in NB.
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Figure 4.7 Ratio of the promoter activity versus optical density in R5 media.
Ratio o f  the luminescence versus O.D. 450 nm in R5 media
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Figure 4.8 Ratio of the promoter activity versus optical density in tryptone soy 
broth.
Ratio o f the luminescence versus OD 450 nm in TSB media.
1 2 0  -i
100 -
PR86
PSALUX1
20 -
16 24 30 
Time (h)
48 72
131
L
um
in
es
ce
nc
e/
O
.D
.4
50
 
nr
Figure 4.9 Ratio of the promoter activity versus optical density when the culture
was inoculated from a pre-culture.
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Figure 4.10 Ratio of the promoter activity versus optical density when the
culture was inoculated directly from spores.
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4.4.2 Expression studies in the bldB background.
In the wild-type background expression of the promoter starts early and activity 
increases progressively until the 26 h time point when it reaches the maximum 
activity. Activity o f the promoter is down regulated from then on reaching very low 
activity at the 28 h time point. After that time point the activity continues to be low 
until it completely dies off at 42 h time point (Figure 4.11). On the other hand, on the 
bldB background the activity of the esxAB promoter appears to be upregulated. 
Activity of the promoter starts at the 23 h of growth (Figure 4.11). The promoter is 
only active between time points 23 h to 26 h but the activity is quite high. The 
modifications on the expression pattern of the promoter strongly suggest that BldB 
seems to have an effect on modulating the activity of the esxAB promoter.
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Figure 4.11. Ratio of the prom oter activity versus growth rate of the esxAB
prom oter in the bldB  background (Tryptone Soy Broth).
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4.5 Conclusion.
The RT-PCR experiments confirm that the esxAB genes constitute an operon. 
Therefore complementation should be attainable using a two gene construct. In terms 
of the mutant phenotype it also corroborates the fact that disruption of esxB will have 
a polar effect on esxA transcription.
The promoter of the esxAB genes is conditionally expressed. Expression studies in 
solid media showed that the promoter starts to be upregulated during the onset of 
aerial growth. On the other hand when S. coelicolor is grown in liquid cultures the 
activity o f the promoter is most active during the late exponential phase. The activity 
is nil until after 13 h of growth when the promoter activity is upregulated getting to 
the peak of expression at approximately 14 h. From then on the promoter is 
downregulated progressively diminishing, becoming nil after 42 h o f growth. It is 
clear that bldB has a role in modulating the activity of the esxAB promoter. In the bldB 
background the promoter is upregulated 9 fold which indicates that BldB either 
directly or indirectly represses expression of this divergently transcribed operon.
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CHAPTER V
PROTEIN STUDIES OF STREPTOMYCES 
COELICOLOR EsxA AND EsxB.
C hapter 5: Protein studies of Streptomyces coelicolor esxA and esxB.
5.1 Introduction.
This chapter focuses on elucidating the properties of the EsxAB proteins. Firstly since the 
S. coelicolor cluster is an ancestral cluster I analysed if the proteins were functional. I 
analysed the interaction of the proteins using a Bacteriomatch two-hybrid E. coli 
approach to determine if the EsxA and EsxB proteins mimic their MTB orthologues 
behaviour and hence form an heterodimer. I went on to explore in detail the sub-cellular 
localisation o f the EsxAB proteins, with the idea that this could provide me with some 
clues to their function and also would enable me to test which member/s o f the esxl 
cluster were essential for the secretion of the proteins, if secreted. The experiments where 
in the main performed in liquid media.
5.2 Two-hybrid interaction studies.
The BacterioMatch II two-hybrid system detects protein-protein interactions based on 
transcriptional activation. The EsxB protein (the bait) was fused to the full-length 
bacteriophage X repressor protein (A,cl, 237 amino acids), containing the amino-terminal 
DNA-binding domain and the carboxyl terminal dimerization domain. EsxA the target 
protein was fused to the N-terminal domain of the a-subunit o f RNA polymerase (248 
amino acids). The bait is tethered to the X operator sequence upstream of the reporter 
promoter through the DNA-binding domain of Ax:I. When the bait and target interact, they 
recruit and stabilize the binding of RNA polymerase at the promoter and activate the 
transcription of the carbenicillin resistance gene. Downstream of the carbenicillin marker,
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there is a second reporter, lacZ that confers that ability to metabolise P- galactosidase for 
extra validation of the bait and target interaction (Figure 5.1).
To be able to apply this methodology it was necessary to construct two plasmids, the bait 
and the target plasmids. The bait plasmid pBT would contain the X cl repressor subunit 
fused in frame with the coding sequence of the esxB gene (Figure 5.2). It is important that 
the DNA encoding the bait protein be inserted so that the bait protein is expressed in the 
same reading frame as the Xcl protein. The target plasmid pTRG should contain the a- 
subunit o f the RNA polymerase in frame with the coding sequence o f esxA. DNA 
encoding the target protein must be inserted in frame with the a-RNA polymerase 
protein.
Plasmid pSA2 (Chapter 2) was subjected to site- directed mutagenesis to create an Xmal 
site at the start codon of EsxB. The modified plasmid was called pSA2mtl then a second 
mutation was introduced also by site- directed mutagenesis to create a BamHl site at the 
beginning of the coding sequence of esxA; the resulting plasmid was called pSA2mt2. 
pSA2mt2 was restricted with Xmal and BamHl to excise the desired fragment containing 
the esxB coding sequence. Then esxB was directionally cloned into pBT that had 
previously being digested with Xmal and BamHl. Recombinant molecules resulting from 
the ligation reaction after being electroporated into the E. coli XL 1-Blue MRF strain 
(supplied by the BacterioMatch Two-hybrid vector kit to propagate plasmids) were 
analysed by restriction analysis. Recombinant plasmids were then sequenced to confirm 
the insertion contained the complete coding sequence of EsxB (Figure 5.3).
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For the construction o f pTRGEST, pSA2mt2 was restricted with BamW\ and Xho\ and the 
desired fragment containing the EsxA coding sequence was directionally cloned into 
pTRG that had previously being digested with BamW\ and Xhol. Recombinant molecules 
resulting from the ligation reaction after being electroporated into the E. coli XL 1-Blue 
MRF strain were analysed by restriction analysis. Recombinant plasmids were then 
sequenced to confirm the insertion had the complete coding sequence o f EsxA.
Prior to commencing two-hybrid interaction assays using the recombinant bait and target 
plasmids pBTCFP and pTRGEST, respectively I determined whether specific 
recombinants were suitable for detecting protein-protein interactions. Cotransformation 
of the BacterioMatch II reporter strain using recombinant pBTCFP plasmid and the 
empty pTRG vector should not produce a significant number of colonies on Selective 
Screening Medium. Likewise, cotransformation o f the reporter strain using pTRGEST 
plasmid and the empty pBT vector should not produce a significant number o f colonies 
on this medium. No significant growth was observed in either of the cotransformation 
experiments; therefore I proceeded to the two-hybrid interaction assays.
The recombinant plasmids pBTCFP and pTRGEST were co-transformed into the 
BacterioMatch II two-hybrid system reporter cells (Chapter 2). The positive control in 
this experiment was pBT and pTRG plasmids containing the coding sequence o f proteins 
known to interact. The negative controls were: recombinant pBTCFP plasmid/pTRG 
vector; and pTRGEST plasmid/ pBT vector. Once cotransformations were plated on 
selective media the results strongly indicated that the EsxA and EsxB proteins interact.
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The experiment was repeated three times always yielding identical results. To further 
validate the interaction the expression of the second reporter gene lacZ was examined. 
Colonies from fresh screening plates were transferred to selective media containing 
carbenicillum/tetracycline/chloramphenicol/ IPTG. The positive control, negative control 
and putative interacting clones, that grew on the selective media were plated. The 
production of p-Galactosidase was visually scored for colonies from each combination. 
As predicted, the positive control and putative colonies that indicated interaction of the 
proteins appeared blue, whereas the negative control appeared white (Figure 5.4).
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Figure 5.1. Diagrammatic representation of the Bacteriomatch 2-Hybrid approach.
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Figure 5.2 Construction of expression plasmid pBTCFP.
Plasmid pSA2 was mutagenized to create an Xmal site at the start codon o f EsxB. The 
modified plasmid was called pSA2mtl which in turn was modified to create a BamHl site 
at the beginning of the coding sequence of esxA; the resulting plasmid was called 
pSA2mt2. pSA2mt2 was restricted with Xmal and BamHl to excise the desired fragment 
containing the esxB coding sequence. Then esxB was directionally cloned into pBT that 
had previously being digested with Xmal and BamHl.
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Figure 5.3 Construction of expression plasmid pTRGEST.
Plasmid pSA2 was mutagenized to create an Xmal site at the start codon of EsxB. The 
modified plasmid was called pSA2mtl which in turn was modified to create a BamHl site 
at the beginning of the coding sequence of esxA; the resulting plasmid was called 
pSA2mt2. For the construction of pTRGEST, pSA2mt2 was restricted with BamHl and 
Xhol and the desired fragment containing the EsxA coding sequence was directionally 
cloned into pTRG that had previously being digested with BamHl and Xhol
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Figure 5.4. Plate showing the validation plate using the p-Galactosidase reporter.
\m \^ /^jlarget
‘SE313SSB" __ ____
Positive control pBT-LGF2 & pTRG-GALl 1 P*( 1)
pBT& pTRG (6)
pBTCFP & pTRGESTtj 
Clones (2- 5)
*pBT-LGF2: dimerization domain o f  the Gal4 transcriptional activator; pTRG-GALl 1 P:Gal 11 protein
§pBTCFP: EsxB fused to full-length bacteriophage A. repressor
pTRGEST: EsxA fused to N-terminal domain o f  the a  subunit o f  RNA polymerase.
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5.3. Sub-cellular localisation of EsxA using a translational fusion to a hexa-histidine 
tag.
Prior to commencing experiments to localise EsxA I intended to detect EsxB. A 
polyclonal antibody was purchased raised against the EsxB protein. Several approaches 
were taken to detect the protein: using solid and liquid media to grow the strains, 
different sampling time points etc. Finally the antibody finished and these preliminary 
experiments were still not successful.
In order to localise EsxA I employed an anti- His antibody readily available from Qiagen. 
The hexa- histidine tag alternative was cheaper to purchase and also the detection was 
facilitated because the method of detection consists of a single antibody fused to the 
horseradish peroxidase enzyme eliminating the need of a secondary antibody. A plasmid 
pSAHISl (Figure 5.6) was constructed that contained EsxA C- terminus fused to a Hexa- 
histidine tag. Three plasmids were used for this cloning experiment: pET26b(+) digested 
Xhol and Xmal, provided the Histidine tag followed by terminal repeats; pSAXhoI a 
derivative of pSA2 mutagenised to introduce a Xhol site at the end of the esxA coding 
sequence; and pSET152 provided the plasmid backbone and was digested Bam HI and 
EcoRV to linearise the plasmid. The three vector fragments were ligated directionally and 
putative recombinant colonies investigated by restriction enzyme and sequence analysis. 
This plasmid was transferred into S. coelicolor M l45 by intergeneric conjugation. At last 
the Ml45/pSAHIS1 was ready to be tested and I was eager to continue the studies. I had 
to decide which method I was to use for the purification step. Reviewing the literature I 
searched for protocols to concentrate proteins contained in the culture filtrate. Most of the
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protocols consisted of precipitating the protein so that it would come out of solution. One 
of the several protocols I found suggested to precipitate the supernatant with 
Trichloroacetic acid (TCA), the method was practical and yielded results. Prior to the 
precipitation method I tried to enrich for proteins of molecular weight below 20 kDa 
using MW filters but I failed to detect any protein. Exploiting the data from the analysis 
of gene expression (Chapter 4), I could choose optimal conditions with which to grow the 
cultures to detect the His- tagged protein.
5.3.1 Localisation of EsxA in Streptomyces coelicolor M145.
The initial experiment was performed by growing M145/pSAHISl strain in liquid culture 
using the tryptone soy broth (TSB) as the luciferase experiments suggested that the 
expression of the esxAB promoter was very active on this particular culture media. I 
obtained the samples at 24 h at the peak of expression (when the cultures were inoculated 
from spore suspensions). The volume of culture grown was also critical and I found that 
50 ml of culture was the right volume. This volume, when transferred to sterile Falcon 
tubes produces about 45 ml of supernatant for the TCA precipitation of extracellular 
proteins and 5 ml of cells to use for the intracellular detection (Chapter 2). The first 
experiment (Figure 5.5) was performed extracting protein from the intracellular and 
extracellular fractions. The amount of protein although visualised using Coomassie 
staining was not quantified at this stage. I was able to detect the EsxA::His protein in 
both fractions; this was a huge step forward, as experiments using the anti-EsxB 
polyclonal antibody only yielded detection on one occasion. The positive control on this 
experiment was CrgA::His that had previously being successfully detected in-house. The
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experiment was repeated yielding the same results before proceeding to further analysis. 
The plasmid introduced by intergeneric conjugation to carry out this work was pSAHISl 
that is apramycin resistant (Figure 5.6). This plasmid was ideal for experiments 
performed on the wild- type strain but it could not be used on the mutants that were 
apramycin resistant like the pSAHISl plasmid. To solve this problem plasmid pSAHIS2 
was constructed by replacing the apramycin cassette of the pSAHISl plasmid with a 
hygromycin cassette (Figure 5.7). The pSAHIS2 construct was introduced into the wild- 
type strain and the esxAB mutant strains. The succeeding western experiments were 
carried out using the pSAHIS2 hygromycin construct. This part of the analysis concluded 
that the EsxA protein was secreted and could be readily detectable in the intracellular and 
extracellular fraction in the wild- type background. In addition this experiment provided 
the first evidence that EsxA::His6 was fully functional as when the plasmid was 
conjugated into the esxB mutant the protein could be detected in the western blot and so 
the construct was used for the complementation studies (Chapter 3).
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Figure 5.5. Western blot detecting EsxA::His in the wild-type M145 background.
Lane 1, positive control CrgA::His; Intracellular fraction: Lane 2, M l45; Lane 3, 
M 145/pSAHIS1; Extracellular fraction: Lane 4, M l45; Lane 5 & 6, Ml45/pSAHIS1 
array of samples obtained in different precipitation experiments; Lane 8, positive control 
CrgA::His6.
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Figure 5.6 Construction of an integrative plasmid pSAHISl containing esxA 
carboxy terminal histidine tagged and esxB genes.
Plasmid pSAHISl was made using pSET152 BamHl- EcoRV as the plasmid backbone, 
ligated to pSAXhoI (derivative of pSA2 with an in-frame Xhol site at the end of esxA 
coding sequence) digested BamHl-Xhol and Xhol-Smal fragment from pET26S(+) 
containing the Histidine tag. All fragments were ligated in this order.
E coR \' (5-190/ 
EcoRJ (5500)
HuuIIU (44901
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Figure 5.7 Construction of a pSAHIS2 hygromycin resistant integrative plasmid 
containing esxA carboxy terminal histidine tagged.
Plasmid pSAHISl (Chapter 2), was modified to be able to complement the mutants esxA 
and esxB that were apramycin resistant. The apramycin cassette was replaced by the 
hygromycin cassette to create pSAHIS2.
BamHl (1)
Xho (1208)
His lug
pSAHISlHiikJIII (5980)
terminal repeats
Sma (2208)
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5.3.2 Sub-cellular localisation o f  EsxA different mutant backgrounds.
To progress it was necessary to know whether there were any essential component/s for 
the secretion of EsxA. Fortunately I had made an array of mutants from the esxl cluster 
of S. coelicolor and I only had to introduce the pSAHIS2 plasmid by intergeneric 
conjugation to continue to the next phase of the analysis. The pSAHIS2 plasmid was 
conjugated into three mutants in which other genes of the esxl cluster were disrupted and 
into the esxB mutant. I chose three conserved genes from the esxl cluster, some that 
literature suggested that were essential for EsxAB secretion in M. tuberculosis and some 
that were not or that at the time it was still not clear how they contributed to the putative 
secretion system. The first gene was SC05721 encoding an amino-terminal 
transmembrane protein that contains an ATP/GTP binding site; the second gene was 
SC05722 encoding a subtilisin like cell wall associated serine protease; finally I selected 
SC05734 encoding a DNA segregation ATPase, FtsK-like chromosome partitioning 
protein (3x ATP/GTP binding sites) with an amino-terminal transmernbrane domain.
I also wanted to know if EsxA protein would be secreted in the absence of EsxB its 
known interacting partner. To examine if EsxA secretion was dependent upon EsxB I 
introduced a deletion on the pSAFHS2 plasmid creating the new plasmid pSAHIS3 
(Figure 5.8) that contains a deletion that disrupted the esxB reading frame, hopefully 
rendering the esxB transcript aberrant. This plasmid was conjugated into M l45, esxA and 
esxB strains.
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The whole experiment was executed as in the wild-type experiments. For this western 
experiment I intended to load the same amount of protein for each sample (Figure 5.9). 
This western consisted only of the proteins extracted from the extracellular fraction 
although the cells were kept at -70° C for later examination. The results were 
encouraging as they suggested that two of the three proteins I selected for the study were 
indeed essential for the secretion of EsxA. SC05721 an amino-terminal transmembrane 
protein and SC05734 DNA segregation ATPase were required for the secretion. When 
the pSAHIS3 construct was introduced into the M l45 strain there was a reduction in the 
secretion of EsxA::His6. A possible explanation for that was that the deletion in esxB has 
a polar effect reducing the expression of esxA and/or, as I was only detecting the 
EsxA::His6 protein, if dimerisation with EsxB is a requirement for EsxA secretion, both 
the EsxA and EsxA::His6 counterpart for binding had to compete with EsxB hence the 
decreased concentration of EsxA::His6 protein extracellularly. More importantly the 
experiment showed that the e.sx5/pSAHIS3 strain did not secrete EsxA::His6. The next 
step was to confirm whether the protein was still synthesized but kept intracellularly as a 
result from the inability of the incomplete secretion system to function correctly.
The intracellular samples were processed and visualised in the Coomassie stain (Figure 
5.10) to estimate that the samples were of good quality. Samples were then analysed 
using the Bradford quantification method to estimate the amount of sample to add into 
the western experiment. Equivalent amount of protein was loaded into each well. The 
results showed that EsxA protein could be detected intracellularly in SC05722, SC05721 
and SC05734 mutant backgrounds (Figure 5.10). The experiment also showed that in the
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wild- type background the pSAHIS3 construct affected the accumulation of EsxA as 
limited amounts of the protein were detected. No protein was detected in the esxB/ 
pSAHIS3 possibly due to the fact that the polar effects on both constructs (the plasmid 
and the chromosome) completely abolish the expression of the esxA gene. Subsequently 
the experiments were repeated, to confirm the results and also to test the e,s;o4/pSAHIS3. 
Until now I could not explain how the disruption of the esxB gene could affect so 
dramatically the accumulation of EsxA::His6 intracellularly.
Figure 5.11 shows the results from an extracellular fraction Western blot experiment 
corroborating the above results. This experiment incorporates the esxv4/pSAHIS3 strain. 
The experiment shows that in the SC05722 mutant, EsxA::His6 was secreted in normal 
amounts. On the other hand, both the SC05721 amino-terminal transmembrane protein 
and SC05734 DNA segregation ATPase are required for efficient secretion. In the 
M145/pSAHIS3 strain EsxA::His6 detection was low too. The e.s;ri?/pSAHIS3 strain did 
not secrete EsxA::His6, suggesting that EsxA could not be secreted in the absence of 
EsxB. The £5x4/pSAHIS3 strain secreted EsxA::His6 in barely detectable low quantities.
The results from the intracellular fraction western blot experiment (Figure 5.12) 
corroborate the results obtained in the previous analysis (Figure 5.10) incorporating the 
e.sx4/pSAHIS3 strain. The results showed that EsxA::His6 protein could be detected 
intracellularly in SC05721, SC05722 and SC05734 mutant backgrounds. The 
experiment also showed that in the wild- type background the pSAHIS3 construct 
affected the accumulation of EsxA::His6 as there was limited amount of the protein being
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detected. In the esxB/ pSAHIS3 strain there was no detection of the EsxA::His6 protein. 
For the esxA/ pSAHIS3 construct only minor amounts of the EsxA: :His6 protein could be 
detected.
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Figure 5.8. Construction of an integrative plasmid pSAHIS3 containing esxA 
carboxy terminal histidine tagged with a deletion in the esxB gene that alters the 
reading frame.
Plasmid pSAHIS2 was modified by restricting Bgl\ and religating, this procedure 
generated a three basepairs deletion in esxB coding sequence that would affect the 
reading frame and possibly abolish esxB normal translation. The resulting plasmid was 
called pSAHIS3.
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Figure 5.9. W estern blot using anti-His antibody to detect EsxA ::H is  tag in different
m utant backgrounds from the extracellular fraction.
a, Coomassie. b. Western blot: Lanes: 1, M 145/pSAHIS 1; 2, M I45/pSA HISl (different 
samples tested); 3, esxBIpSAHIS2; 4, SC05734  (F7sA'-like)/pSAHlS2; 5, SC05722  
{Serine protease-)/pSAH!S2; 6. SC05721 (ATP/GTP binding 5/7e-)/pSAllIS2; 7, 
M145/pSAHlS3 (ABglW alteration o f  the reading frame in esxB); 8, esxB/ pSAHIS3.
b
M W  1 2  3 4 5 6 7 8
1 5kDa-  
c. 1 2.4kDa-  
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Figure 5.10. Coomassie stained intracellular samples and western blot using anti- 
His antibody to detect EsxA::His6 in different mutant backgrounds from the 
intracellular fraction.
a, Coomassie: Lanes: 1, Molecular weight marker; 2, SC05722  (Serine protease- 
)/pSAHlS2; 3, SC05721 (ATP/GTP binding «7e-;/pSAHIS2; 4, SC 05734  (FtsK- 
1 ike)/pSAHIS2; 5, M145/pSAHIS3 6, esxBI pSAHIS3. b, Western blot: Lanes: 1, 
SC05722  (Serine proteas,e-)/pSAHIS2; 2, SC05721 (ATP/GTP binding site-)/pSAHIS2; 
3. SC05734  (RsW-like)/pSAHIS2; 4. M 145/pSAHIS3; 5, esxB! pSAH!S3.
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Figure 5.11. Coomassie stain and western blot detecting EsxA::His6 in different
mutant backgrounds from the extracellular fraction.
a. Coomassie; Lanes I, Molecular weight marker; 2, M !45/pSAHIS2; 3, SC05722  
(Serine prolea.se )/p S A HIS2; 4, SC05721 (ATP/GTP binding .s7/e-/pSAHIS2
<m-5/pSAHIS2; 5, SC05734  (Fte£-like)/pSAHIS2; 6, M145/pSAHIS3; 7,
esx5/pSAHIS3; 8, esxAi pSAHIS3; 9. e.sx#/pSAHIS2.
b. Western blot: Lanes 1, M 145/pSAHlS2; 2, SC05722 (Serine /?roteos,e)/pSAHIS2; 3, 
SCO5721 (ATP/GTP binding «te-J/pSAHIS2 e5x5/pSAHIS2; 4 SC05734  (FtsK- 
like)/pSAHIS2; 5, M 145/pSAHIS3; 6, esxB/pSAU\S3; 7, esxA! pSAHIS3; 8, 
ejxF/pSAHIS2.
a 1 2 3 4 5 6  7 8  9
Figure 5.12. Western blot and coomassie stain detecting EsxA::His tag in different
mutant  backgrounds from the in tracellu lar fraction.
a. Coomassie; b. Western blot.
Lanes 1, Molecular weight marker, 2, M 145/pSAHIS2; 3, SC05722 (,Serine protease- 
)/pSAH!S2; 4, SC05721 (ATP/GTP binding .v/7e-;/pSAHIS2; 5, SC05734 (FtsK- 
1 ike)/pS AH 1S2; 6, M 145/pSAHIS3; 7, esxB/pSAH\S3; 8, esxA/ pSAHIS3; 9, 
e.vx/?/pSAHIS2.
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5.4 Conclusion
Two-hybrid analysis confirmed that EsxA and EsxB interact. Western hybridisation 
studies indicate that EsxA protein is secreted into the extracellular milieu. There is also 
evidence provided by this analysis suggesting that the EsxA protein is secreted by a 
dedicated secretory apparatus o f which I have identified two key components and without 
them the protein fails to be secreted. It also appears that in the absence of EsxB there is a 
decrease of EsxA in the intracellular fraction, possibly due to protein turnover.
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CHAPTER VI 
DISCUSSION
C hapter 6. Discussion.
The investigations completed in this thesis present the functional characterisation o f the 
esxl alternative protein secretion system in S. coelicolor. The system is analogous to the 
novel tat/sec independent secretion systems described in several mycobacteria and is only 
existent in Gram positive bacteria. The system was initially pointed out by Gey van 
Pittius et al. 2002 who carried out a comparative genetic study based in the M. 
tuberculosis cluster. The S. coelicolor locus closely resembles M. tuberculosis Region 4 
locus that is believed to be the original ancestor of the cluster. Gey van Pittius et al. 
discovered that the cluster only featured in high-G+C Gram- positive bacteria, although 
they noted that multiple duplications of the cluster have taken place only in 
Mycobacterium.
6.1 S. coelicolor esxAB, particular function of the genes in the bacteria.
The first part of this discussion is focused in the phenotype o f the mutants in S. 
coelicolor. The esxAB genes are affected in morphological development. Their absence 
leads to delayed development of aerial hyphae of the organism and defects in sporulation. 
There is retardation in the maturation o f the spores that is very noticeable as immature 
spores lack the polyketide spore pigment. As a consequence of this, the mutants appear 
light grey even when the spores have fully developed. The phenotype o f the mutants is 
apparent macroscopically and more importantly microscopically. In the micrographs of 
the mutants it is evident that there is a reduced number of spore chains as compared to the 
number of spore chains in the M145 wild- type. Interestingly the microscopic phenotype 
of the esxA and esxB mutants is that septation of the aerial hyphae occurs in an irregular
mode. Nevertheless each mutant has a specific phenotype. The esxA mutant is 
characterized by irregular pre- spore compartments and also that a significant percentage 
of the compartments are significantly smaller than the norm. On the contrary the esxB 
mutant is typified by the presence of larger compartments. Both mutants also contain an 
unusual high number of ghost compartments devoid of DNA (Chapter 3). The mutations 
of the esxAB genes were successfully complemented using a plasmid pSAHIS2 
containing the two genes. This construct was also use successfully to detect the protein in 
vivo. The phenotype o f the SC05724 mutant had been previously described by Piret et al. 
1985. Piret isolated recombinant phages (obtained from a phage library o f wild-type S. 
coelicolor DNA), which restored wild-type morphological development to several bldB 
mutants. Piret’s study focused on bldB, but the mutant of the gene divergently 
transcribed, esxB, was also obtained and reported as being delayed in sporulation. 
Interestingly, deletion o f the esxl genes affects morphology of mycobacteria. The earliest 
study to report alterations in colony morphology of RD1 deletion mutants was described 
by Calmette on 1927, and since then (Pym, Brodin et al. 2002) and later (Brodin, 
Majlessi et al. 2004) described the phenotype in M. tuberculosis and M. microti. In 
addition to the phenotypic and complementation analysis, I confirmed that the genes 
constitute an operon. The expression studies linked the esxAB genes to the onset of 
sporulation providing more clues that associate the genes as having a developmental 
function. The genes were not expressed during germination or later phases o f growth. 
The activity of the promoter was only present during the commencement of sporulation 
(Chapter 4).
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Gene expression of the esxAB genes at the transcriptional level is affected by the 
pleiotropic regulator BldB. bldB mutants have a bald phenotype, are defective in 
antibiotic production and de-regulated in catabolite repression (Pope, Green et al. 1996). 
BldB either directly or indirectly represses the activity o f the esxAB promoter (Chapter 
4). The bid genes are know to be the key component that through an extracellular 
signalling cascade define the onset of aerial mycelium formation. The phenotype o f the 
mutants being delayed in aerial development together with the evidence that BldB 
modulates the esxAB promoter activity suggests that the genes have a morphological role 
in the bacteria.
Recent research indicates that the CFP-10 (EsxB of M. tuberculosis) protein interacts 
with members of the Signal Recognition Pathway (SRP) and components o f the sec/YEG 
translocon (Singh, Mai et al. 2006). CFP-10 protein has been demonstrated to interact 
with Rv0686, a member of the SRP-GTPase family. Other members o f this family 
include SRP and its receptor SR. CFP-10 interacts with FtsQ (Rv2151c), a cell division 
protein too; it is believed that FtsQ might be responsible for the targeting o f CFP-10 to 
the sec/YEG translocon. CFP-10 also interacts with ClpCl (Rv3596c), a protein that is 
involved in secretion, gene regulation, protein refolding and degradation. (Singh, Mai et 
al. 2006) provided the first evidence that the specialised secretion system could be linked 
to evolutionary conserved SRP and sec/YEG systems.
This new evidence provides an interesting background to the work performed in this 
thesis, linking the esxAB genes with secretory components and cell division proteins. It
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could be argued that the S.coelicolor esxAB mutant phenotypes resulted as a consequence 
of abolished EsxAB complex secretion. This was proven not to be the case as mutants of 
the SC05722 and SC05734 genes defective in secretion did not have any obvious 
phenotype on MS media. This indicates that EsxAB might perform an intracellular role. 
This is supported in view of the fact that there is detectable accumulation o f EsxA::His6 
intracellularly in the wild- type.
Converse et al. 2005 argues that the Snm pathway may be regulated, like some sec- 
independent pathways from gram negative bacteria. This was proposed because the M. 
tuberculosis EsxAB proteins are not secreted in every growth conditions, only being 
secreted in certain culture media.
EsxB interacts with the intracellular cell division protein FtsQ potentially modulating its 
activity. In the absence of intracellular EsxB, FtsQ function may be affected. This might 
explain irregular cell division of aerial hyphae.
6.2. Analogy of the putative sec/tat independent secretion system with other 
mycobacteria.
The esxl system from S. coelicolor resembles the ESAT apparatus from Mycobacterium 
tuberculosis and also the Snm secretion system of Mycobacterium smegmatis described 
by (Converse and Cox 2005). The esxl/snm  secretion system is specific for members of 
the 100 residue protein family represented by ESAT-6. The locus is composed of genes 
encoding ATP binding proteins, putative ABC transporters, serine proteases and other 
membrane associated proteins. Western hybridisation studies in S. coelicolor indicated
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that EsxA protein is secreted into the extracellular milieu. My analysis o f the locus 
confirmed that EsxB, SC05722, and SC05734 were all essential for effective EsxA 
secretion and/ or stability. It seems that in the absence of EsxB there is a decrease of 
EsxA in the intracellular fraction. All the evidence suggests that the system is fully 
functional and analogous to others described in the literature (Table 6.1). In M. 
tuberculosis inactivation of gene pe35 (Rv3872) impaired expression o f CFP-10 and 
ESAT-6, suggesting a role in regulation. Genes Rv3868, Rv3869, Rv3870, Rv3871, and 
Rv3877 encoding an ATP-dependent chaperone and translocon were essential for 
secretion of ESAT-6 and CFP-10 in contrast to ppe68, Rv38 73 and Rv3876, whose 
inactivation did not alter secretion of ESAT-6 (Brodin, Majlessi et al. 2004).
Why would be the ESAT system be conserved in non- pathogenic bacteria when the 
system is so strongly associated with virulence in M. tuberculosis? It is well documented 
that bacteria devise dedicated secretion apparatus for the exporting of effector molecules 
to mediate infection. Those systems have been extensively studied in Gram negative 
bacteria. (Champion, Stanley et al. 2006) reviewed that Mycobacterium tuberculosis uses 
the esxl/snm system to deliver virulence factors into host macrophages during infection. 
The extracellular function of EsxAB in S. coelicolor is yet to be elucidated.
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Table 6.1 Homology between the components of the Snm secretion system in S. 
coelicolor and M. tuberculosis.
S. coelicolor genes Essential M. tuberculosis genes Essential
: SC05717c Not tested Rv3876 (snm3) Yes
; SC05721 Yes Rv3869 (snm6) Yes
SCO5722 No Rv3883 No
SCO5724 Yes Cfp-10 Yes
SCO5725 n/a Esat-6 n/a
SCO5734 Yes Rv3870
(snml)/Rv3871 (snm 2)
Yes
SC05735 Not tested Rv3877(snm4) Yes
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6.3 Conclusion.
The model organism S. coelicolor has proved to be a good working model to understand 
the Snm (secretion in mycobacteria) secretion apparatus. The results indicate that the 
modus operandim of the M. tuberculosis, M. smegmatis and S. coelicolor systems are 
analogous.
Future work would include characterisation of the interactions in S. coelicolor between 
the proteins from the cluster to determine which proteins interact with which. It also 
would be interesting to continue to explore which components o f the system are 
dispensable for the secretion. The study could be extended by trying to export the M. 
tuberculosis orthologues. The components that are essential for the secretion o f the 
substrates are also analogous to those of M  tuberculosis. I believe that possibly S. 
coelicolor could be an excellent host for the production of recombinant peptides or 
proteins from M. tuberculosis to be used as recombinant vaccines.
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